About this data
Pipeline and clinical trial information here comes primarily from ClinicalTrials.gov. A listing on ClinicalTrials.gov means a study has been registered — not that a treatment is proven safe, effective, or FDA-approved. Investigational treatments may never be approved. Who can join a trial is decided only by that trial's own study team.
Sinemet CR
- Company
- VA Office of Research and Development
- Mechanism
- Mechanism not yet reported
- Route
- Route not yet reported
- Recruiting trials
- 38 recruiting
Efficacy results: Not yet reported
38 recruiting studies currently listed on ClinicalTrials.gov.
Data source: ClinicalTrials.gov · trial data as of Nov 17, 2026
Find a Clinical Trial Near Me
See recruiting studies for Sinemet CR and check eligibility with the study team.
Trial details
-
Recruiting NCT NCT00004847
Diagnosis of Pheochromocytoma
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 3000 participants Est. completion 2048-11-30 1 siteOther conditions: Pheochromocytoma, Endocrine Disease, Endocrine DiseasesView official trial listing → -
Recruiting NCT NCT03872102
Facilitating Diagnostics and Prognostics of Parkinsonian Syndromes Using Neuroimaging
University of Texas Southwestern Medical Center 90 participants Est. completion 2026-12-31 1 siteOther conditions: Parkinson Disease, Multiple System Atrophy, Progressive Supranuclear PalsyView official trial listing → -
Recruiting NCT NCT04205604
18FluoroLDOPA PET Imaging for the Detection and Localization of Focal Congenital Hyperinsulinism
Not yet reported Miguel Pampaloni 50 participants Est. completion 2026-12-01 1 siteOther conditions: Congenital HyperinsulinismView official trial listing → -
Recruiting NCT NCT04558112
Improving Therapeutic Learning for PTSD
Not yet reported University of Wisconsin, Madison 120 participants Est. completion 2023-12 2 sitesOther conditions: PTSD, Post Traumatic Stress DisorderView official trial listing → -
Recruiting NCT NCT04735627
Real-Time Levodopa Level Monitoring in Parkinson Disease
Not yet reported University of California, San Diego 20 participants Est. completion 2028-02 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT04957095
Motor Network Physiology
Not yet reported University of Texas Southwestern Medical Center 120 participants Est. completion 2028-12-01 1 site Stand-aloneOther conditions: Parkinson Disease, Essential TremorView official trial listing → -
Recruiting NCT NCT05285683
The Role of Brain Dopamine in Chronic Pain
Not yet reported University of Rochester 10 participants Est. completion 2027-12-22 1 siteOther conditions: Chronic PainView official trial listing → -
Recruiting NCT NCT05656586
Udall Project 2 Aim 2A&C
University of Minnesota 36 participants Est. completion 2028-03-01 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT05711082
REALITY MONITORING AND DOPAMINE
Not yet reported Hôpital le Vinatier 39 participants Est. completion 2027-02-28 1 siteOther conditions: NeurosciencesView official trial listing → -
Recruiting NCT NCT05909267
Dopamine Modulation of Motivation and Motor Function in Major Depression & Inflammation
Not yet reported Charite University, Berlin, Germany 165 participants Est. completion 2026-07 1 siteOther conditions: Depressive Disorder, MajorView official trial listing → -
Recruiting NCT NCT06013956
Personalized Real-Time DBS and PD Mechanisms
Not yet reported David Escobar 25 participants Est. completion 2028-06-30 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06075771
Dopaminergic Therapy for Anhedonia - 2
Not yet reported Emory University 70 participants Est. completion 2027-01 1 site Stand-aloneOther conditions: Anhedonia, DepressionView official trial listing → -
Recruiting NCT NCT06234995
Cortical Electrophysiology of Response Inhibition in Parkinson's Disease
Not yet reported Emory University 80 participants Est. completion 2027-09 2 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06316232
DBS and Levodopa for Treating Freezing of Gait in Parkinson's Disease
Not yet reported IRCCS Istituto delle Scienze Neurologiche di Bologna 20 participants Est. completion 2026-12-31 1 siteOther conditions: Freezing of Gait, Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06489483
Action Regulation Behavioral
Not yet reported University of Texas Southwestern Medical Center 50 participants Est. completion 2027-11 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06570824
rTMS as an Intervention for Levodopa-induced Dyskinesia
Not yet reported Danish Research Centre for Magnetic Resonance 68 participants Est. completion 2027-12-01 1 siteOther conditions: Dyskinesia, Drug-Induced, Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06667726
An Investigational Scan (18F-DOPA PET/CT) for Improving the Clinical Management of Brain Tumors
Not yet reported Mayo Clinic 47 participants Est. completion 2028-05-31 1 siteOther conditions: Malignant Brain NeoplasmView official trial listing → -
Recruiting NCT NCT06765668
A Study of CREXONT (Carbidopa and Levodopa) Extended-Release Capsules in Participants With Parkinson's Disease
Not yet reported Impax Laboratories, LLC 220 participants Est. completion 2026-08-06 27 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06772220
Pilot Study of Open Label Homocysteine Management Therapy in Levodopa-treated Parkinson's Disease
Not yet reported Oregon Health and Science University 150 participants Est. completion 2025-12-31 1 siteOther conditions: Parkinson&Amp;#39;s DiseaseView official trial listing → -
Recruiting NCT NCT06785298
Fexofenadine as Adjuvant Therapy in Parkinson Disease
Not yet reported, Not yet reported Tanta University 46 participants Est. completion 2026-12-20 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06831500
Feasibility Study Assessing the Effect of Carbidopa/Levodopa Ratio on Orthostatic Hypotension in Multiple System Atrophy - Parkinsonian Type and Parkinson Disease.
Not yet reported, Not yet reported Julien Bally 36 participants Est. completion 2026-11 2 sites Stand-aloneOther conditions: Multi-system Atrophy - Parkinsonian Type, Orthostatic Hypotension, Dysautonomic, Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT06884722
Brain Mechanisms of Social Perception in Parkinson's Disease
Not yet reported Hospices Civils de Lyon 83 participants Est. completion 2027-04 1 siteOther conditions: Social Perception in Parkinson's DiseaseView official trial listing → -
Recruiting NCT NCT06891781
Investigating Adaptive Deep Brain Stimulation in Parkinson's Disease Management
Not yet reported Newronika 104 participants Est. completion 2029-08 1 siteOther conditions: Parkinson Disease, IdiopathicView official trial listing → -
Recruiting NCT NCT06928519
Efficacy and Safety of Entacapone Combined With Madopar in the Treatment of Early Parkinson's Disease: An Observational, Multicenter, Case-Control Study
Yousheng Xiao 216 participants Est. completion 2027-06-30 1 siteOther conditions: Parkinson Disease (PD)View official trial listing → -
Recruiting NCT NCT06949865
AI-Enhanced Optimization of Acute Levodopa Challenge Test
Beijing Tiantan Hospital 2000 participants Est. completion 2026-12-31 1 siteOther conditions: Vascular Parkinsonism, Drug-induced Parkinsonism, Corticobasal Degeneration (CBD), Parkinson Disease (PD), Dementia With Lewy Body Disease, Progressive Supranuclear Palsy(PSP), Multiple System Atrophy (MSA)View official trial listing → -
Recruiting NCT NCT07151378
Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Counteract Dopaminergic Desensitization and Neuropsychiatric Complications in Parkinson's Disease
Not yet reported University Hospital Tuebingen 150 participants Est. completion 2030-09-22 7 sites Stand-aloneOther conditions: PARKINSON DISEASE (Disorder)View official trial listing → -
Recruiting NCT NCT07213219
PET-MRI of Reward System in Parkinson's Disease With RBD
Not yet reported University Hospital, Clermont-Ferrand 44 participants Est. completion 2029-01-01 3 sites Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Recruiting NCT NCT07229651
Metformin in Parkinson Disease
Not yet reported, Not yet reported Tanta University 60 participants Est. completion 2027-09-20 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07229664
Vinpocetine in Patients With Parkinsonian Disease
Not yet reported, Not yet reported Tanta University 60 participants Est. completion 2027-11-20 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07246278
Celecoxib in Parkinson Disease as Adjuvant Therapy
Not yet reported, Not yet reported Tanta University 80 participants Est. completion 2026-11-28 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07370532
Etoricoxib in Patients With Parkinsonian Disease
Not yet reported Ihab Elsayed Hassan 60 participants Est. completion 2027-11-20 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07432958
A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations
Not yet reported Appello Pharmaceuticals, Inc. 150 participants Est. completion 2028-01-03 30 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07513441
A Trial of Lu AF28996 in Participants With Parkinson's Disease (PD)
Not yet reported H. Lundbeck A/S 10 participants Est. completion 2027-05-31 4 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07725562
VG081821AC Tablets for Early to Mid-stage Parkinson's Disease
Not yet reported, Not yet reported Zhejiang Vimgreen Pharmaceuticals, Ltd. 152 participants Est. completion 2027-10-31 1 siteOther conditions: Parkinson Disease (PD)View official trial listing → -
Recruiting NCT NCT07797790
Real-world Patient Experiences With Inbrija®
Merz Therapeutics GmbH 120 participants Est. completion 2027-09 2 sitesOther conditions: Parkinson Disease (PD), Parkinson's Disease, Off Episodes of Parkinson DiseaseView official trial listing → -
Recruiting NCT NCT07810296
Comparison of Benzhexol and Procyclidine for Tremor in Tremor-Predominant Parkinson's Disease
Not yet reported safia bano 88 participants Est. completion 2027-07 1 site Stand-aloneOther conditions: Parkinson Disease (PD)View official trial listing → -
Recruiting NCT NCT07839793
A 12-Week Study of Flexilev With the OraFID Device and App in Parkinson's Patients
Not yet reported Navamedic AB 58 participants Est. completion 2027-06-30 5 sites Stand-aloneOther conditions: PARKINSON DISEASE (Disorder)View official trial listing → -
Recruiting NCT NCT07935889
Advanced Imaging-Guided Standard Versus Dose-Intensified Radiation Therapy for the Treatment of Newly Diagnosed Glioblastoma, SAGA 2.0 Trial
Not yet reported Mayo Clinic 292 participants Est. completion 2035-11-30 8 sitesOther conditions: Glioblastoma, IDH-WildtypeView official trial listing → -
Completed NCT NCT00001849
New Imaging Techniques in the Evaluation of Patients With Ectopic Cushing Syndrome
Not yet reported Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) 95 participants Est. completion 2019-04-26 1 siteOther conditions: Cushing Syndrome, Endocrine DiseaseView official trial listing → -
Completed NCT NCT00001928
Intravenous Levodopa for the Diagnosis of Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 25 participants Est. completion 2000-07 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00001929
Treatment of Parkinson's Disease With Eliprodil
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2001-01 1 siteOther conditions: Movement Disorders, Parkinson DiseaseView official trial listing → -
Completed NCT NCT00004576
Study of LY300164 for the Treatment of Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2000-08 1 siteOther conditions: Dyskinesias, Parkinson DiseaseView official trial listing → -
Completed NCT NCT00004733
Timing of Levodopa Treatment in Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) Est. completion 2004-02 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00006077
Effects of Monoamine Reuptake Inhibitor NS2330 in Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 50 participants Est. completion 2003-07 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00006337
KW-6002 to Treat Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 16 participants Est. completion 2002-01 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00009048
EMD 128130 for the Treatment of Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2003-12 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00013624
Riluzole to Treat Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2005-03 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00024622
PET Scanning in Parkinson s Disease
National Institute of Mental Health (NIMH) 502 participants 1 siteOther conditions: Schizophrenia, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00036296
Effects of Talampanel on Patients With Advanced Parkinson's Disease
Not yet reported, Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 22 participants Est. completion 2007-02Other conditions: Dyskinesias, Parkinson Disease, Movement DisordersView official trial listing → -
Completed NCT NCT00040209
JP-1730 to Treat Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 30 participants Est. completion 2005-07 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00076674
Levetiracetam Treatment of L-dopa Induced Dyskinesias
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2005-10 1 siteOther conditions: Dyskinesias, Parkinson DiseaseView official trial listing → -
Completed NCT NCT00086294
ACP-103 to Treat Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2007-11-15 1 siteOther conditions: Parkinson's Disease, DyskinesiasView official trial listing → -
Completed NCT NCT00089622
Lisuride Patch to Treat Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2007-03-31 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00096720
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Imaging in Parkinson's Disease
Not yet reported Institute for Neurodegenerative Disorders 112 participants Est. completion 2007-05 13 sitesOther conditions: Parkinson Disease, Parkinsonian SyndromeView official trial listing → -
Completed NCT NCT00099268
Efficacy and Safety of Carbidopa/Levodopa/Entacapone in Patients With Parkinson's Disease Requiring Initiation of Levodopa Therapy
Not yet reported Novartis Pharmaceuticals 747 participants Est. completion 2008-11 73 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00102284
Neuromodulation and Language Acquisition (Project Stage Ia)
Not yet reported University Hospital Muenster 100 participants Est. completion 2005-04 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00102869
Dopaminergic Enhancement of Learning and Memory in Aphasia
Not yet reported University Hospital Muenster 12 participants Est. completion 2008-12 1 siteOther conditions: Cerebrovascular Accident, AphasiaView official trial listing → -
Completed NCT NCT00103805
Improved Language Acquisition With Levodopa
Not yet reported University Hospital Muenster 20 participants Est. completion 2005-08 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00108667
Talampanel to Treat Parkinson's Disease
Not yet reported National Institute of Neurological Disorders and Stroke (NINDS) 40 participants Est. completion 2006-02 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT00111371
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dyslexia
Not yet reported University Hospital Muenster 100 participants Est. completion 2015-10 1 siteOther conditions: DyslexiaView official trial listing → -
Completed NCT NCT00125567
Stalevo in Early Wearing-Off Patients
Not yet reported Orion Corporation, Orion Pharma 223 participants Est. completion 2009-03 19 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00129181
Study of the Effects of Dopaminergic Medications on Dopamine Transporter Density in Subjects With Parkinson's Disease
Not yet reported Institute for Neurodegenerative Disorders 30 participants Est. completion 2007-01 9 sitesOther conditions: Parkinson Disease, Parkinsonian SyndromeView official trial listing → -
Completed NCT NCT00134251
Ascending Dose Tolerability/Safety of SLV308 for the Treatment of Parkinson's Disease
Not yet reported Solvay Pharmaceuticals 10 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00134784
Long-Term Dopamine Transporter Imaging and Clinical Assessment of Parkinson's Disease Progression
Not yet reported Institute for Neurodegenerative Disorders 142 participants Est. completion 2007-05 Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00134966
A Study to Evaluate Fixed Dose Carbidopa/Levodopa/Entacapone Versus Immediate Release Carbidopa/Levodopa
Not yet reported Novartis 493 participants Est. completion 2007-09 60 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00139867
A Multicenter, Open-label Trial to Assess Subject Preference of PARCOPA, Carbidopa/Levodopa Orally Disintegrating Tablets, Compared to Conventional Carbidopa/Levodopa Tablets in Subjects With Stable Parkinson's Disease
Not yet reported UCB Pharma Est. completion 2004-05 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00139880
A Single Center, Randomized, Double-blind, Crossover Pilot Trial Comparing the Onset of Action of Parcopa™ With Sinemet® in Subjects With Stable Parkinson's Disease
Not yet reported UCB Pharma Est. completion 2005-08 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00141518
Long-term Study of Duodopa (Levodopa/Carbidopa) in Advanced Parkinson's: Health Outcomes & Net Economic Impact
Not yet reported AbbVie (prior sponsor, Abbott) 77 participants Est. completion 2011-04 Stand-aloneOther conditions: Advanced Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00143026
Study to Compare the Effect of Treatment With Carbidopa/Levodopa/Entacapone on the Quality of Life of Patients With Parkinson's Disease. This Study is Not Recruiting in the United States
Not yet reported Novartis 184 participants Est. completion 2006-06 18 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00144209
Assess Efficacy and Safety of the Dopamine Agonist Pramipexole Versus Levodopa / Benserazide (Madopar® DR) in Patients With Restless Legs Syndrome
Not yet reported Boehringer Ingelheim 58 participants Est. completion 2005-02 6 sitesOther conditions: Restless Legs SyndromeView official trial listing → -
Completed NCT NCT00148512
A Randomized, Double-blind, Placebo-controlled, Five Parallel Groups Efficacy and Safety Study of NS 2330 (Tesofensine) (0.125 mg, 0.25 mg, 0.5 mg and 1.0 mg) Administered Orally Once Daily Over 14 Weeks in Levodopa Treated Parkinson Patients With Motor Fluctuations
Not yet reported Boehringer Ingelheim 254 participants Est. completion 2005-02 50 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00160576
Levetiracetam Treatment in Adult Subjects With Parkinson's Disease Experiencing Troublesome Dyskinesias
Not yet reported UCB Pharma 30 participants Est. completion 2004-11Other conditions: Idiopathic Parkinson DiseaseView official trial listing → -
Terminated NCT NCT00174239
Study Of Cabaser and Sinemet CR For The Treatment Of Nighttime Symptoms Associated With Parkinson's Disease.
Not yet reported Pfizer 220 participants Est. completion 2005-09 14 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00199355
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Not yet reported Kyowa Kirin Co., Ltd. 75 participants Est. completion 2006-03 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00199368
An Extension of Istradefylline in Parkinson's Disease Patients Who Have Completed Studies 6002-EU-007, 6002-US-013 or 6002-US-018
Not yet reported Kyowa Kirin, Inc. 1100 participants Est. completion 2007-05 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00199381
An Extension of Istradefylline in North American Parkinson's Disease Patients Who Have Completed Study 6002-INT-001
Not yet reported Kyowa Kirin, Inc. 504 participants Est. completion 2008-10 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00199394
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease
Not yet reported Kyowa Kirin Co., Ltd. 405 participants Est. completion 2005-11 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00199407
A Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Not yet reported Kyowa Kirin, Inc. 230 participants Est. completion 2006-01 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00199420
A Study of Istradefylline (KW-6002) in Treating Patients With Parkinson's Disease on Levodopa
Not yet reported Kyowa Kirin, Inc. 580 participants Est. completion 2005-12 2 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00200447
An Open-Label Feasibility/Pilot Study With [123I]-IBZM SPECT (DOPA-SYN)
Not yet reported Molecular NeuroImaging 3 participants Est. completion 2004-09Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00203034
Multicenter Study of Rasagiline in Parkinson's Disease Patients Using Levodopa and Experiencing Motor Fluctuations
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 472 participants Est. completion 2003-01 4 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00203060
Effectiveness, Tolerability and Safety of Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa
Not yet reported Teva Neuroscience, Inc. 404 participants Est. completion 2000-07Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00203164
Study to Evaluate the Safety and Tolerability of Rasagiline in Advanced Parkinson's Disease Patients
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 254 participants Est. completion 2006-09 6 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00203177
Rasagiline in Advanced Parkinson's Disease Patients With Motor Fluctuations Treated With Levodopa/Carbidopa Therapy.
Not yet reported Teva Branded Pharmaceutical Products R&D, Inc. 254 participants 8 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00203957
Study of KW-6002 (Istradefylline) in Parkinson's Disease in Patients With Motor Response Complications on Levodopa
Not yet reported University of Chicago 10 participants Est. completion 2007-02 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00208611
Vitamin B12 Status and Response to Vitamin B12 Supplementation in Patients With Parkinson's Disease
Not yet reported, Not yet reported Emory University 57 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00218023
Medications for Stopping Cocaine Dependence and Preventing Relapse
Not yet reported The University of Texas Health Science Center, Houston 101 participants Est. completion 2012-04 1 site Stand-aloneOther conditions: Cocaine Abuse, Cocaine-Related DisordersView official trial listing → -
Completed NCT NCT00218075
Behavioral Therapy Combined With Carbidopa/Levodopa for the Treatment of Cocaine Dependence
Not yet reported The University of Texas Health Science Center, Houston 200 participants Est. completion 2007-10 1 siteOther conditions: Cocaine Abuse, Cocaine-Related DisordersView official trial listing → -
Completed NCT NCT00219284
Effects of Carbidopa/Levodopa/Entacapone on Motor Function and Quality of Life in Patients With Parkinson's Disease
Not yet reported Novartis Pharmaceuticals 359 participants Est. completion 2008-07 42 sites Stand-aloneOther conditions: Parkinson's Disease With End of Dose Wearing OffView official trial listing → -
Completed NCT NCT00223691
Treatment of Orthostatic Hypotension in Autonomic Failure
Not yet reported Vanderbilt University 389 participants Est. completion 2017-01 1 site Stand-aloneOther conditions: Autonomic Failure, Orthostatic HypotensionView official trial listing → -
Completed NCT NCT00224263
Efficacy and Safety of Lingzhi in Patients With Early Parkinson's Disease
Not yet reported Xuanwu Hospital, Beijing 360 participants Est. completion 2008-02 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00228150
Study of the Effect of SR57667B on the Progression of Symptoms in Patients With Parkinson's Disease
Not yet reported Sanofi 564 participants Est. completion 2006-04 13 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00239564
Pharmacokinetics and Pharmacodynamics of IPX054 in Subjects With Parkinson's Disease
Not yet reported, Not yet reported Impax Laboratories, LLC 12 participants Est. completion 2007-12 2 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00244387
Rotigotine Patch in Subjects With Advanced Stage, Idiopathic Parkinson's Disease Who Are Not Well Controlled on Levodopa
Not yet reported UCB Pharma 506 participants Est. completion 2005-07 1 siteOther conditions: Parkinson Disease, IdiopathicView official trial listing → -
Completed NCT NCT00245700
Adherence of Stalevo, Entacapone and Levodopa
South Glasgow University Hospitals NHS Trust 14 participants Est. completion 2006-07 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00247247
Comtess® Versus Cabaseril® as Add-on to Levodopa in the Treatment of Parkinsonian Patients Suffering From Wearing- Off.
Not yet reported Orion Corporation, Orion Pharma 300 participants Est. completion 2005-06 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00253084
Comparison of IPX054 and Immediate-Release Carbidopa-Levodopa in Patients With Parkinson's Disease
Not yet reported Impax Laboratories, LLC 12 participants Est. completion 2007-12 2 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00272688
Continuous Delivery of Levodopa in Patients With Advanced Idiopathic Parkinsons Disease - Cost-benefit
Not yet reported University Hospital, Akershus 10 participants Est. completion 2009-05 2 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00282152
Deep Brain Stimulation (DBS) for Early Stage Parkinson's Disease (PD)
Not yet reported Vanderbilt University Medical Center 37 participants Est. completion 2015-10 Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00286897
The Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Not yet reported Eisai Limited 702 participants Est. completion 2007-08 118 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT00291733
Levetiracetam Administration for the Management of Levodopa-Induced Dyskinesias in Parkinson's Disease
Not yet reported 1st Hospital of Social Security Services 50 participants Est. completion 2007-10 1 siteOther conditions: Levodopa Induced DyskinesiaView official trial listing → -
Terminated NCT NCT00296959
Topiramate as a Treatment for Levodopa-Induced Dyskinesia in Parkinson's Disease
Not yet reported University Health Network, Toronto 20 participants Est. completion 2007-03 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00302146
Positron Emission Tomography (PET) Imaging in People With Gaucher Mutations
National Human Genome Research Institute (NHGRI) 64 participants 1 siteOther conditions: Parkinson Disease, Gaucher DiseaseView official trial listing → -
Status unknown NCT NCT00306124
Dopaminergic Enhancement of Learning and Memory in Healthy Adults and Patients With Dementia/Mild Cognitive Impairment
Not yet reported University Hospital Muenster 120 participants Est. completion 2008-03 1 siteOther conditions: Alzheimer's Disease, Mild Cognitive Impairment, HealthyView official trial listing → -
Completed NCT NCT00307450
Efficacy and Safety of Levetiracetam Versus Placebo on Levodopa-induced Dyskinesias in Advanced Parkinson's Disease
Not yet reported Technische Universität Dresden 34 participants Est. completion 2009-07 2 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00314288
Sarizotan in Parkinson Patients With L-dopa-induced Dyskinesia
Not yet reported EMD Serono 360 participants Est. completion 2003-07 51 sitesOther conditions: Parkinson's Disease, DyskinesiaView official trial listing → -
Completed NCT NCT00331149
A Comparison of Ropinirole Immediate Release With Ropinirole Prolonged Release in Patients With Advanced Parkinson's
Not yet reported GlaxoSmithKline 343 participants Est. completion 2007-08-29 81 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00335153
Levodopa-Carbidopa Intestinal Gel Open-Label Study in Advanced Parkinson's Disease
Not yet reported AbbVie (prior sponsor, Abbott) 354 participants Est. completion 2012-06 83 sites Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00357994
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Not yet reported AbbVie (prior sponsor, Abbott) 36 participants Est. completion 2011-10 15 sites Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00360308
Efficacy, Safety and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Not yet reported Eisai Limited 723 participants Est. completion 2008-04 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00360412
A Study of E2007 as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Not yet reported Eisai Inc. 997 participants Est. completion 2008-04 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00360568
Safety/Efficacy Study of Levodopa-Carbidopa Intestinal Gel in Parkinson's Subjects
Not yet reported AbbVie (prior sponsor, Abbott) 62 participants Est. completion 2012-10 22 sites Stand-aloneOther conditions: Dyskinesias, Parkinson's Disease, Severe Motor FluctuationsView official trial listing → -
Completed NCT NCT00363727
Onset Motor Complications Using REQUIP CR (Ropinirole Controlled-release) As Add-on Therapy To L-dopa In Parkinson's
Not yet reported GlaxoSmithKline 209 participants Est. completion 2006-01 69 sitesOther conditions: Parkinson's Disease, Parkinson Disease, DyskinesiasView official trial listing → -
Completed NCT NCT00366184
Influence of Theta Burst Stimulation and Carbidopa-Levodopa on Motor Performance in Stroke Patients
National Institute of Neurological Disorders and Stroke (NINDS) 20 participants Est. completion 2010-05-26 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT00368108
Efficacy, Safety, and Tolerability of E2007 in Levodopa Treated Parkinson's Disease Patients With Motor Fluctuations
Not yet reported Eisai Inc. 752 participants Est. completion 2008-01 114 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00373087
COMT Polymorphism and Entacapone Efficacy
Not yet reported Assistance Publique - Hôpitaux de Paris 60 participants Est. completion 2009-11 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00381472
Investigational Parkinson's Disease In Patients Not Well Controlled On L-dopa
Not yet reported GlaxoSmithKline 393 participants Est. completion 2004-12 76 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00391898
Efficacy of Levodopa/Carbidopa/Entacapone vs Levodopa/Carbidopa in Parkinson's Disease Patients With Early Wearing-off
Not yet reported Novartis 95 participants Est. completion 2008-06 26 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00399477
A Non-Blinded Study Demonstrating the Effectiveness and Safety of Azilect Alone or in Combination Therapy in Parkinson's Disease
Not yet reported Teva Neuroscience, Inc. 200 participants Est. completion 2007-07 Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00406029
Dyskinesia in Parkinson's Disease (Study P04501)
Not yet reported Merck Sharp & Dohme LLC 253 participants Est. completion 2008-11-03Other conditions: Parkinson Disease, Movement Disorders, Central Nervous System Diseases, Neurodegenerative Diseases, Brain DiseasesView official trial listing → -
Completed NCT NCT00406588
SLV308 for Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations
Not yet reported Solvay Pharmaceuticals 295 participants Est. completion 2008-05 87 sites Stand-aloneOther conditions: Advanced Stage Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00415740
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Not yet reported Novartis 42 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00415831
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Not yet reported Novartis 42 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00415844
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone Under Fasting Conditions in Healthy Volunteers
Not yet reported Novartis 42 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00415922
Bioequivalence Study of Carbidopa/Levodopa/Entacapone Combination vs. Carbidopa/Levodopa Combination Plus Entacapone in Healthy Volunteers
Not yet reported Novartis 42 participants 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT00431366
Sequence Effect in Parkinson's Disease
National Institute of Neurological Disorders and Stroke (NINDS) 24 participants Est. completion 2008-12-24 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00432393
Effect of Levodopa-Carbidopa on Visual Function in Patients With Recent-Onset Nonarteritic Anterior Ischemic Optic Neuropathy
Not yet reported Shahid Beheshti University of Medical Sciences Est. completion 2003-04 1 siteOther conditions: Nonarteritic Anterior Ischemic Optic NeuropathyView official trial listing → -
Completed NCT NCT00438607
Dose-Finding Safety Study of BIIB014 in Combination With Levodopa in Moderate to Late Stage Parkinson's Disease
Not yet reported Biogen 83 participants Est. completion 2009-04 15 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT00439049
Substance Abuse Pre-Treatment Screening Study
The University of Texas Health Science Center, Houston 7500 participants Est. completion 2026-06 1 siteAlcohol use disorder Other conditions: Cocaine Abuse, Cocaine Dependence, Opiate Dependence, Substance AbuseView official trial listing → -
Withdrawn NCT NCT00451633
The Effect Of E2007 On Pharmacodynamic Responses To Levodopa Among Patients With Parkinson's Disease Who Experience Dyskinesia And Motor Fluctuations
Not yet reported Eisai Inc. 5 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00455507
A Phase 2b Study of Istradefylline (KW-6002) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Not yet reported Kyowa Kirin Co., Ltd. 363 participants Est. completion 2008-08 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00456586
12-Week, Double-Blind, Placebo-Controlled, Randomized Study of the Efficacy of 40 mg/Day KW-6002 in Parkinson's Disease Patients on Levodopa/Carbidopa
Not yet reported Kyowa Kirin, Inc. 180 participants Est. completion 2003-06 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00456794
12-Week, Double-Blind, Placebo-Controlled Study of 20 and 60 mg/Day Istradefylline in Parkinson's Disease Patients on Levodopa/Carbodopa
Not yet reported Kyowa Kirin, Inc. 325 participants Est. completion 2003-10 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00460954
A Multiple-Dose Study of Sinemet® CR (Carbidopa/Levodopa) in Healthy Subjects
Bristol-Myers Squibb 20 participants Est. completion 2007-08 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00462007
Study to Evaluate Initiation of Stalevo in Early Wearing-off
Not yet reported Orion Corporation, Orion Pharma 115 participants Est. completion 2007-12 20 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00466167
Pivotal Study in Advanced Parkinsons Disease Patients
Not yet reported Boehringer Ingelheim 517 participants 76 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00467597
Developing Objective Measures of Levodopa Induced Dyskinesia: (Study 1)
US Department of Veterans Affairs 36 participants Est. completion 2013-10 1 siteOther conditions: Dyskinesias, Movement Disorders, Parkinson DiseaseView official trial listing → -
Terminated NCT NCT00477802
Botulinum Toxin Type A (Botox) in the Management of Levodopa-Induced Peak-Dose Dyskinesias in Parkinson's Disease
Not yet reported University of Cincinnati 8 participants Est. completion 2008-12 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00485069
REQUIP (Ropinirole Hydrochloride) IR Long-Term Phase 4 Study
Not yet reported GlaxoSmithKline 123 participants Est. completion 2009-12 22 sitesOther conditions: Parkinson Disease, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00491998
PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets
Not yet reported, Not yet reported Vernalis (R&D) Ltd 27 participants Est. completion 2007-11 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00501969
An Open-Label Extension Trial to Assess the Safety of Long-Term Treatment of Rotigotine in Advanced-Stage Parkinson's Disease
Not yet reported UCB Pharma 395 participants Est. completion 2008-12 53 sitesOther conditions: Advanced Stage Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00505622
Evaluation of the Long-term Safety, Tolerability, and Efficacy of Perampanel (E2007) as an Adjunctive Therapy in Levodopa Treated Parkinson's Disease Subjects With Motor Fluctuations
Not yet reported Eisai Limited 328 participants Est. completion 2008-04 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00505843
A Study of MK0657 in Parkinson's Disease Patients (0657-006)
Not yet reported Merck Sharp & Dohme LLC 18 participants Est. completion 2008-02Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00507715
Study of the Modification of the Pharmacokinetic Profile of Levodopa by the Fiber Plantago Ovata Husk
Not yet reported Rottapharm Spain 18 participants Est. completion 2006-11 1 siteOther conditions: Parkinson's Disease, IdiopathicView official trial listing → -
Completed NCT NCT00537017
Follow Up Safety Study of SCH 420814 in Subjects With Parkinson's Disease (P05175)
Not yet reported Merck Sharp & Dohme LLC 140 participants Est. completion 2009-11-19Other conditions: Parkinson Disease, Neurodegenerative Diseases, Central Nervous System Diseases, Movement Disorders, Brain DiseasesView official trial listing → -
Completed NCT NCT00537485
A Placebo-controlled Study for SPM 962 in Early Parkinson's Disease Patients
Not yet reported, Not yet reported Otsuka Pharmaceutical Co., Ltd. 180 participants Est. completion 2009-12 6 sitesOther conditions: Early Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00552474
Deep Brain Stimulation to Treat Symptoms of Parkinson's Disease
Not yet reported Abbott Medical Devices 136 participants Est. completion 2016-11 15 sitesOther conditions: Parkinson Disease, Movement DisordersView official trial listing → -
Completed NCT NCT00558337
Efficacy, Safety, and Pharmacokinetics/Pharmacodynamic Study of L-Dopa/Carbidopa To Treat Parkinson's Disease
Not yet reported Osmotica Pharmaceutical US LLC 78 participants Est. completion 2008-12 9 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00560508
A 12-week Study of Pramipexole Extended Release (ER) in Patients With Parkinson's Disease (PD), Followed by a 52-week Long-term Treatment Period
Not yet reported, Not yet reported Boehringer Ingelheim 112 participants 19 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Terminated NCT NCT00562198
PET-Study: Effects of Single Doses of Stalevo and Levodopa/Carbidopa on Striatal 11C-Raclopride Binding
Not yet reported Orion Corporation, Orion Pharma 16 participants Est. completion 2008-05 5 sitesOther conditions: Parkinson´s DiseaseView official trial listing → -
Completed NCT NCT00582673
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients, and Safety in Combination With L-dopa
Not yet reported Novartis 31 participants 5 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00590122
Parcopa Versus Carbidopa-levodopa in a Single Dose Cross-over Comparison Study
Not yet reported Baylor College of Medicine 20 participants Est. completion 2008-11 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00599339
Transdermal Rotigotine User Surveillance Study
UCB Pharma 2195 participants Est. completion 2014-04 211 sitesOther conditions: Idiopathic Parkinson DiseaseView official trial listing → -
Withdrawn NCT NCT00601978
Carbidopa/Levodopa Versus Carbidopa/Levodopa/Entacapone on Markers of Event Related Potentials (ERPs) in Patients With Idiopathic Parkinson's Disease (PD) and End-of-dose Wearing Off
Not yet reported Novartis Pharmaceuticals Est. completion 2009-11Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00605553
Study to Evaluate SYN115 in Parkinson's Disease
Not yet reported Biotie Therapies Inc. 30 participants Est. completion 2009-05 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00607451
Safety, Tolerability, PK and PD Study of Neu-120 in the Treatment of Levodopa-induced Dyskinesia
Not yet reported, Not yet reported Neurim Pharmaceuticals Ltd. 8 participants Est. completion 2016-08-27 1 siteOther conditions: Levodopa-induced DyskinesiaView official trial listing → -
Completed NCT NCT00610103
Phase 2 Clinical Study of KW-6500 in Parkinson's Disease Patients With Motor Response Complication on Levodopa Therapy
Not yet reported Kyowa Kirin Co., Ltd. 16 participants Est. completion 2008-10 4 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00613301
Special Survey on Parkinson's Disease (PD) Patients Without Concomitant Use of L-Dopa
Boehringer Ingelheim 416 participants 119 sitesOther conditions: Parkinson DiseaseView official trial listing → -
No Longer Available NCT NCT00624741
Compassionate Use Study of Pergolide in Patients With Parkinson's Disease
Bausch Health Americas, Inc.Other conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00625547
A Study to Determine the Efficacy and Safety of Cabergoline for the Treatment of Patients With RLS
Not yet reported Pfizer 361 participants Est. completion 2004-12 50 sites Stand-aloneOther conditions: Restless Legs SyndromeView official trial listing → -
Completed NCT NCT00627640
Safinamide in Idiopathic Parkinson's Disease (IPD) With Motor Fluctuations, as add-on to Levodopa
Not yet reported Newron Pharmaceuticals SPA 549 participants Est. completion 2012-03 121 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00632762
Long-Term Effects of Amantadine in Parkinsonian (AMANDYSK)
Not yet reported University Hospital, Toulouse 80 participants Est. completion 2011-01 5 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00634556
Dopaminergic Effects on Cortical Function in Tourette's (Levodopa Protocol)
Not yet reported Washington University School of Medicine 49 participants Est. completion 2010-10 1 site Stand-aloneOther conditions: Tourette SyndromeView official trial listing → -
Terminated NCT NCT00642356
Carbidopa/Levodopa/Entacapone Versus Immediate Release (IR) Carbidopa/Levodopa on Non-motor Symptoms in Patients With Idiopathic Parkinson's Disease and Demonstrating Non-motor Symptoms of Wearing Off
Not yet reported Novartis 14 participants Est. completion 2009-05 21 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00647140
Clinical Evaluation of 18F-DOPA Positron Emission Tomography in Medullary Thyroid Cancer
Not yet reported Assistance Publique - Hôpitaux de Paris 29 participants Est. completion 2010-02 1 siteOther conditions: Thyroid Neoplasm, Thyroid Carcinoma, Medullary CarcinomaView official trial listing → -
Completed NCT NCT00660387
Study of Efficacy, Safety and Tolerability of Levodopa-Carbidopa Intestinal Gel in Levodopa-Responsive Parkinson's Subjects
Not yet reported AbbVie (prior sponsor, Abbott) 35 participants Est. completion 2011-10 14 sites Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00660673
Open Label Continuation Treatment Study With Levodopa-Carbidopa Intestinal Gel in Advanced Parkinson's Disease
Not yet reported AbbVie 262 participants Est. completion 2021-11-30 61 sites Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00664157
Facial Expression Recognition of Emotion and Categorization of Emotional Words in Parkinson's Disease. Impact of L-Dopa and Deep Brain Stimulation of Subthalamic Nucleus
Not yet reported University Hospital, Clermont-Ferrand 80 participants Est. completion 2009-10 1 siteOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00664209
Treating H. Pylori in Parkinson's Patients With Motor Fluctuations
Not yet reported University of California, Los Angeles 64 participants Est. completion 2012-06 1 siteOther conditions: Parkinson's Disease, Helicobacter Infections, Motor FluctuationsView official trial listing → -
Completed NCT NCT00666653
Effects of a Dopamine Agonist on Pharmacodynamics of Levodopa in Parkinson's Disease
Not yet reported Oregon Health and Science University 13 participants Est. completion 2007-05 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00692328
Expectation and Response to Levodopa and Acupuncture in Parkinson's Disease
Not yet reported Oregon Health and Science University 63 participants Est. completion 2007-02 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00713583
Carbidopa/Levodopa Combined With Behavioral Therapy for the Treatment of Cocaine Dependence
Not yet reported The University of Texas Health Science Center, Houston 85 participants Est. completion 2011-12 1 site Stand-aloneOther conditions: Cocaine DependenceView official trial listing → -
Completed NCT NCT00715520
Neurobiological Principles Applied to the Rehabilitation of Stroke Patients
Not yet reported Emory University 33 participants Est. completion 2016-09 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Withdrawn NCT NCT00758368
Comparison of Continuous and Pulsatile Apomorphine in Parkinson's Disease
Not yet reported Oregon Health and Science University Est. completion 2011-06 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT00762814
The Use of Sensory or Motor Cues Using Electrical Stimulation to Reduce Gait Freezing in Patients With Parkinson Disease
Not yet reported Washington University School of Medicine 4 participants Est. completion 2009-06 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00775853
Biomarkers of Risk of Parkinson Disease
National Institute of Neurological Disorders and Stroke (NINDS) 89 participants Est. completion 2023-01-11 1 siteOther conditions: Parkinson Disease, Autonomic Nervous System Diseases, Pure Autonomic FailureView official trial listing → -
Completed NCT NCT00789672
Pilot Study to Evaluate Levodopa as Treatment for Residual Amblyopia
Not yet reported Jaeb Center for Health Research 33 participants Est. completion 2009-12 1 siteOther conditions: AmblyopiaView official trial listing → -
Terminated NCT NCT00804479
The Long Term Impact of Initiating Pramipexole Versus Levodopa in Early Parkinson's Disease (CALM-PD Cohort Study)
University of Rochester 222 participants Est. completion 2004-03 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00812760
Effect of Levodopa on Human Multifocal Electroretinogram
Not yet reported Medical University of Vienna 20 participants Est. completion 2003-10 1 site Stand-aloneOther conditions: Retinal DiseasesView official trial listing → -
Completed NCT NCT00823836
Clinical Evaluation of Ropinirole Prolonged Release/Extended Release (PR/XR) Tablet for Adjunctive Therapy to L-dopa in Subjects With Advanced Parkinson's Disease
Not yet reported GlaxoSmithKline 302 participants Est. completion 2010-12 54 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00829439
Study on Tolerability of Levodopa/Carbidopa in Children With Angelman Syndrome
Not yet reported Boston Children's Hospital 16 participants Est. completion 2010-06 1 site Stand-aloneOther conditions: Angelman SyndromeView official trial listing → -
Completed NCT NCT00845000
Acute Effects of Preladenant (SCH 420814) on Dyskinesia and Parkinsonism in Levodopa Treated Participants (P05550)
Not yet reported Merck Sharp & Dohme LLC 12 participants Est. completion 2010-05-14 Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00869791
A Study to Compare Pharmacokinetics and Pharmacodynamics of IPX066 to Standard Carbidopa-Levodopa
Not yet reported Impax Laboratories, LLC 27 participants Est. completion 2009-06 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00880620
A Study To Evaluate The Safety And Efficacy Of IPX066 In Subjects With Parkinson's Disease
Not yet reported Impax Laboratories, LLC 381 participants Est. completion 2010-11 60 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00888004
Efficacy and Safety of AFQ056 in Reducing L-dopa Induced Dyskinesias in Parkinson's Disease Patients
Not yet reported Novartis 28 participants 5 sitesOther conditions: Parkinson's Disease, L-dopa Induced DyskinesiaView official trial listing → -
Completed NCT NCT00888186
Different Dyskinesias in Parkinson's Disease and Their Relation to Levodopa Pharmacokinetics
Not yet reported Uppsala University 5 participants Est. completion 2008-05 1 site Stand-aloneOther conditions: Parkinson Disease, DyskinesiasView official trial listing → -
Terminated NCT NCT00903838
A Pilot Study to Assess Efficacy and Safety of Pardoprunox as Adjunct Therapy to L-dopa in the Treatment of Patients With Parkinson's Disease Experiencing Motor Fluctuations and Dyskinesia.
Not yet reported Abbott Products 37 participants Est. completion 2011-05 9 sitesOther conditions: Advanced Stage Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00906828
Pharmacokinetics of Levodopa/Carbidopa Infusion With and Without Oral Catechol-O-methyl Transferase (COMT) Inhibitors
Not yet reported Uppsala University 10 participants Est. completion 2009-11 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT00912977
Prospective Evaluation of Forceplate Measured Levodopa-Induced Dyskinesia
Oregon Health and Science University 10 participants Est. completion 2010-06 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00914134
Duodenal Levodopa Infusion, Quality of Life and Autonomic Nervous System in Parkinson's Disease
Not yet reported University of Helsinki 12 participants Est. completion 2011-01 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00914602
An Exploratory Study of XP21279 (With Lodosyn®) and Sinemet® in Parkinson's Disease Subjects
Not yet reported, Not yet reported XenoPort, Inc. 14 participants Est. completion 2010-01 2 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00918177
An Evaluation of the Pharmacokinetics and Pharmacodynamics of AP09004 in Patients With Parkinson's Disease
Not yet reported Intec Pharma Ltd. 72 participants 7 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00941265
Effect of Dopaminergic Medication on Recovery of Aphasia
Not yet reported University Hospital, Geneva 12 participants Est. completion 2009-08 1 siteOther conditions: AphasiaView official trial listing → -
Withdrawn NCT NCT00947037
Gastric Retentive Carbidopa/ Levodopa in Parkinson's Patients; a One Year, Open Label, Safety Extension Study
Not yet reported Intec Pharma Ltd. 5 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00955045
A Long-Term, Safety Study With a Flexible Dose Range of KW-6002 in Patients With Motor Response Complications on Levodopa/Carbidopa Therapy
Not yet reported, Not yet reported Kyowa Kirin, Inc. Est. completion 2003-10 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00955526
Study of KW-6002 (Istradefylline) for the Treatment of Parkinson's Disease in Patients Taking Levodopa
Not yet reported Kyowa Kirin Co., Ltd. 373 participants Est. completion 2011-02 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00957203
Long-Term Safety Study of KW-6002 (Istradefylline) in Parkinson's Disease Patients
Not yet reported Kyowa Kirin Co., Ltd. 308 participants Est. completion 2012-03 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00974974
A Study To Evaluate The Safety And Efficacy Of IPX066 In Advanced Parkinson's Disease (ADVANCE-PD).
Not yet reported Impax Laboratories, LLC 471 participants Est. completion 2011-03 73 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT00986414
Evaluation of the Efficacy and Safety of AFQ056 in Reducing Moderate to Severe L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Not yet reported Novartis 260 participants 47 sitesOther conditions: Parkinson Disease, DyskinesiasView official trial listing → -
Withdrawn NCT NCT01003002
Natural History of Levodopa-Induced Dyskinesia (LID)
Oregon Health and Science University Est. completion 2020-12 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01023282
Safety and Tolerability Study Evaluating ACR325 in Parkinson's Disease Patients
Not yet reported NeuroSearch A/S 22 participants Est. completion 2011-04 2 sitesOther conditions: Parkinson's Disease, TolerabilityView official trial listing → -
Completed NCT NCT01026428
A Study to Assess the Effect of Safinamide on Levodopa Pharmacokinetics
Not yet reported, Not yet reported Newron Pharmaceuticals SPA 24 participants 2 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01044992
Motor Activation in Multiple System Atrophy and Parkinson Disease: a Positron Emission Tomography (PET) Study
Not yet reported University Hospital, Toulouse 38 participants Est. completion 2006-05 4 sites Stand-aloneOther conditions: Multisystemic AtrophyView official trial listing → -
Completed NCT NCT01049984
Rasagiline as Add on to Dopamine Agonists in the Treatment of Parkinson's Disease
Not yet reported Teva Neuroscience, Inc. 328 participants Est. completion 2012-10 58 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01052948
The Association Between Dopamine Agonists and Cardiac Valvulopathy, Fibrosis and Other Cardiopulmonary Events
Pfizer 86939 participants Est. completion 2009-12Other conditions: Parkinson's Disease, HyperprolactinemiaView official trial listing → -
Completed NCT NCT01064739
Renal Salt Handling in Postural Tachycardia Syndrome Following Dietary Dopa Administration
Not yet reported Vanderbilt University 14 participants Est. completion 2012-12 1 siteOther conditions: Healthy ParticipantsView official trial listing → -
Completed NCT NCT01070628
Levodopa Concentration Profile With Stalevo 75/125 mg
Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01092065
Efficacy and Safety of AFQ056 When Combined With Increased Doses of L-dopa in Parkinson's Disease Patients With Moderate-severe L-dopa Induced Dyskinesia
Not yet reported Novartis 23 participants Est. completion 2011-07 4 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01096186
An Open Label Extension Study of the Safety and Clinical Utility of IPX066 in Subjects With Parkinson's Disease
Not yet reported Impax Laboratories, LLC 617 participants Est. completion 2011-10 81 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01103011
Safety, Tolerability and Pharmacokinetic Profile of Levodopa Administered With Continuous Administration of ND0611
Not yet reported NeuroDerm Ltd. 8 participants Est. completion 2010-10 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01113320
Safinamide in Levodopa Induced Dyskinesia in Parkinson's Disease Subjects
Not yet reported Newron Pharmaceuticals SPA 26 participants Est. completion 2012-01 11 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01130493
A Study to Compare IPX066 and Carbidopa/Levodopa/Entacapone (CLE) Followed by an Open-Label Safety Study of IPX066
Not yet reported Impax Laboratories, LLC 110 participants Est. completion 2012-01 24 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01135407
Visual Selective Attention in Parkinson's Disease
University Hospital, Grenoble 36 participants Est. completion 2010-07 1 siteOther conditions: Visual Attention in Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01140841
A Study of Safety and Tolerability of Fipamezole in Adult Subjects With Parkinson's Disease Who Are Receiving Levodopa
Bausch Health Americas, Inc. 40 participants Est. completion 2010-11 4 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01142739
Phosphorylation of ERK1/2 in Patients With Parkinson's Disease
University Hospital, Bordeaux 30 participants Est. completion 2012-07 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01149811
A Study Comparing the Safety and Tolerability of Two Doses of Fipamezole in Adult Patients With Parkinson's Disease
Bausch Health Americas, Inc. 27 participants Est. completion 2010-11 4 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01154166
A Phase III, Randomised, Double-blind, Placebo-controlled, Parallel Group Study of Six Months Treatment With Ropinirole PR as Adjunctive Therapy in Patients With Parkinson's Disease Who Are Not Optimally Controlled on L-Dopa
Not yet reported GlaxoSmithKline 347 participants Est. completion 2011-09-29 18 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01171313
A Efficacy, Safety and Pharmacokinetic Study of XP21279 and Sinemet® in Parkinson's Disease Subjects
Not yet reported XenoPort, Inc. 35 participants Est. completion 2011-12 12 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01173731
Open Label, Safety, Tolerability and Efficacy of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Not yet reported Novartis Pharmaceuticals 66 participants Est. completion 2013-10 22 sitesOther conditions: Parkinson Disease, Dyskinesia, Drug-Induced, LevodopaView official trial listing → -
Completed NCT NCT01174758
Development of an Instrumented System to Measure Mobility in Parkinson's Disease
Oregon Health and Science University 160 participants Est. completion 2014-10 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01176435
Trial of L-DOPA as a Treatment to Improve Vision in Albinism
Not yet reported University of Minnesota 45 participants Est. completion 2014-12 1 siteOther conditions: AlbinismView official trial listing → -
Completed NCT NCT01187966
Efficacy and Safety of Safinamide (50 and 100mg/Day) Versus Placebo, in Patients With Mid-late Stage Parkinson's Disease
Not yet reported Newron Pharmaceuticals SPA 669 participants Est. completion 2009-02Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01190813
Levodopa for the Treatment of Residual Amblyopia
Not yet reported Jaeb Center for Health Research 139 participants Est. completion 2014-04 1 siteOther conditions: AmblyopiaView official trial listing → -
Completed NCT NCT01191944
Pramipexole Extended Release Versus Pramipexole Immediate Release for 18 Weeks in Chinese Parkinson's Disease (PD) Patients
Not yet reported Boehringer Ingelheim 475 participants Est. completion 2012-01 20 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01211587
A Trial to Explore the Potential Benefit of Safinamide on Cognitive Impairment Associated With Parkinson's Disease
Not yet reported Newron Pharmaceuticals SPA 103 participants 15 sitesOther conditions: Parkinson's Disease With Cognitive ImpairmentsView official trial listing → -
Completed NCT NCT01218425
Dopaminergic Modulation of Cognition and Psychomotor Function
Not yet reported Maastricht University Medical Center 20 participants Est. completion 2012-06 1 site Stand-aloneOther conditions: Dopamine Activity, Episodic Memory Consolidation, Response PreparationView official trial listing → -
Withdrawn NCT NCT01218919
Post Market (Brio™ System) Deep Brain Stimulation (DBS) PD Study
Abbott Medical Devices Est. completion 2013-12Other conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01227655
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients.
Not yet reported Bial - Portela C S.A. 427 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01229332
A Safety, Tolerability and Pharmacokinetic Study of ND0611 on the Top of Different Oral Dosage Forms of Levodopa/Carbidopa in Parkinson's Disease Patients
Not yet reported, Not yet reported NeuroDerm Ltd. 24 participants Est. completion 2011-11 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01268891
Study of Azilect® (Rasagiline) in Levodopa-treated Parkinson's Disease Patients With Motor Fluctuations in Korea
Not yet reported H. Lundbeck A/S 132 participantsOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01281475
A Trial of Levodopa in Angelman Syndrome
Not yet reported, Not yet reported Wen-Hann Tan 67 participants Est. completion 2015-07 7 sites Stand-aloneOther conditions: Angelman SyndromeView official trial listing → -
Completed NCT NCT01283594
Safety and Efficacy Study of SYN115 in Parkinson's Patients Using Levodopa to Treat End of Dose Wearing Off
Not yet reported, Not yet reported Biotie Therapies Inc. 420 participants Est. completion 2012-10 61 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01286935
18-month Study of Long-term Efficacy & Safety of Safinamide as add-on Therapy in Patients With Mid-late Stage PD
Not yet reported Newron Pharmaceuticals SPA 544 participants Est. completion 2010-08Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01291537
Clinical and Economic Impact of Duodopa: Long-term Effectiveness Study in Advanced Parkinson's Disease Patients
Not yet reported Poitiers University Hospital 56 participants 20 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01296464
Comparing Different Levodopa/Carbidopa/Entacapone Treatment Regimens
Not yet reported Orion Corporation, Orion Pharma 27 participants Est. completion 2011-07 5 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01327261
Fasting Comparative Bioavailability of Two Tablet Formulations of Levodopa /Benserazide in Healthy Volunteers
Not yet reported University of Buenos Aires 24 participants Est. completion 2009-12 Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT01330290
Caregivers' and Physicians' Treatment Preference in Parkinson Patients Treated With Neupro® Requiring Caregiver Support
UCB Pharma 148 participants Est. completion 2012-08 54 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01336088
ADX48621 for the Treatment of Levodopa Induced Dyskinesia in Patients With Parkinson's Disease
Not yet reported Addex Pharma S.A. 83 participants Est. completion 2012-02 25 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT01338662
Comparison of the Incidence of Dyskinesia in Parkinson's Disease Who Were Treated With Amantadine or Dopamine Agonist
Seoul National University Hospital 500 participants Est. completion 2022-04 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Withdrawn NCT NCT01351168
Use of Zolpidem in Parkinson's Disease
Not yet reported Rush University Medical Center 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01352819
Post Market (Libra/LibraXP System) Deep Brain Stimulation (DBS) Parkinson's Disease Study
Abbott Medical Devices 21 participants Est. completion 2013-12 6 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT01361373
Dopamine Treatment in Children With Cerebral Palsy With Dystonia- A Double Blind Controlled Study
Not yet reported Shaare Zedek Medical Center 50 participants Est. completion 2012-08 1 siteOther conditions: Dystonic Cerebral PalsyView official trial listing → -
Completed NCT NCT01385592
Evaluation of the Efficacy and Safety of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Not yet reported Novartis Pharmaceuticals 78 participants Est. completion 2012-09 28 sitesOther conditions: Dyskinesias, Parkinson Disease, Movement Disorders, Parkinsonian DisordersView official trial listing → -
Completed NCT NCT01393457
Cognitive Remediation for Cocaine Dependence
Not yet reported The University of Texas Health Science Center, Houston 119 participants Est. completion 2017-02 1 siteOther conditions: Cocaine DependenceView official trial listing → -
Completed NCT NCT01397422
Extended Release Amantadine Safety and Efficacy Study in Levodopa-Induced Dyskinesia (EASED Study)
Not yet reported, Not yet reported Adamas Pharmaceuticals, Inc. 83 participants Est. completion 2013-10 33 sitesOther conditions: Dyskinesia, Levodopa Induced Dyskinesia, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01399905
High and Low Dose Carbidopa Treatment of Parkinson's Disease
Not yet reported Oregon Health and Science University 14 participants Est. completion 2011-05 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01411137
Carbidopa-Levodopa (CD-LD) ER Alone or in Combination With CD-LD IR to IPX066 Followed by IPX066 Extension Safety Study
Not yet reported Impax Laboratories, LLC 43 participants Est. completion 2013-03 8 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01429077
Augmenting Language Therapy for Aphasia: Levodopa
Not yet reported, Not yet reported Shirley Ryan AbilityLab 36 participants Est. completion 2012-03 1 siteCardiovascular disease Other conditions: Nonfluent AphasiaView official trial listing → -
Completed NCT NCT01429207
Capturing Parkinson's Disease Medication Side Effects During Daily Activities
Great Lakes NeuroTechnologies Inc. 15 participants 1 siteOther conditions: Parkinson's Disease, DyskinesiaView official trial listing → -
Completed NCT NCT01437293
Behavioral and Physiological Effects of Cocaine in Cocaine-dependent Participants Treated With Levodopa in Combination With Carbidopa and Entacapone (LCE)
Not yet reported New York State Psychiatric Institute 15 participants Est. completion 2012-04 1 siteOther conditions: Cocaine AbuseView official trial listing → -
Completed NCT NCT01468012
Imaging the Neurobiology of Behavioral and Medication Treatment for Cocaine Dependence
Not yet reported, Not yet reported New York State Psychiatric Institute 23 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Cocaine DependenceView official trial listing → -
Completed NCT NCT01470859
The Effect of Pramipexole on Metabolic Network Activity Compared With Levodopa in Early Parkinson's Disease
Not yet reported Huashan Hospital 30 participants Est. completion 2014-08 1 siteOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01474421
Safety and Efficacy of AQW051 in L-dopa Induced Dyskinesias in Patients With Parkinson's Disease
Not yet reported Novartis Pharmaceuticals 71 participants Est. completion 2013-02-21 24 sitesOther conditions: Dyskinesias, Drug-inducedView official trial listing → -
Completed NCT NCT01479127
Study of Safety, Tolerability, Pharmacokinetics, and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease
Not yet reported AbbVie (prior sponsor, Abbott) 8 participants Est. completion 2012-07 Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01479530
Azilect® (Rasagiline) in Levodopa-treated Parkinson's Patients With Motor Fluctuations in China
Not yet reported H. Lundbeck A/S 321 participants Est. completion 2013-06 18 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01484184
Study to Assess Safety, Tolerability and MTD of a Central Pattern Generator-activating Tritherapy (SPINALON) in Patients With Chronic Spinal Cord Injury
Not yet reported, Not yet reported Nordic Life Science Pipeline Inc. 50 participants Est. completion 2015-08 1 siteOther conditions: Spinal Cord InjuryView official trial listing → -
Completed NCT NCT01484990
A Pharmacokinetic Study of Levodopa and Carbidopa Intestinal Gel in Subjects With Advanced Parkinson's Disease
Not yet reported AbbVie 19 participants Est. completion 2010-09 Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01486628
Study of Subcutaneous Continuous Administration of Levodopa/Carbidopa Solution (ND0612) in Healthy Volunteers
Not yet reported NeuroDerm Ltd. 36 participants Est. completion 2013-06-13 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01491529
Evaluation of the Efficacy and Safety of Modified Release AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Not yet reported Novartis Pharmaceuticals 154 participants Est. completion 2013-04 39 sitesOther conditions: Dyskinesias, Parkinson Disease, Movement Disorders, Parkinsonian Disorders, Anti-Dyskinesia AgentsView official trial listing → -
Completed NCT NCT01491932
Open-label, Long-term Safety Extension Study of AFQ056 in Parkinson's Patients With L-dopa Induced Dyskinesias
Not yet reported Novartis Pharmaceuticals 129 participants Est. completion 2013-10 32 sitesOther conditions: Dyskinesias, Parkinson Disease, Movement Disorders, Parkinsonian Disorders, Anti-Dyskinesia AgentsView official trial listing → -
Completed NCT NCT01494532
A Fixed Dose Study of Ropinirole Prolonged Release as Adjunctive Treatment in Patients With Advanced Parkinson's Disease
Not yet reported GlaxoSmithKline 352 participants Est. completion 2014-11-18 52 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Withdrawn NCT NCT01500707
Single Dose Study to Assess the Pharmacokinetics of SCH 900800 in Subjects With Parkinson's Disease Being Treated With Levodopa (L-DOPA) (P08235)
Not yet reported Merck Sharp & Dohme LLC Est. completion 2013-07Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01515410
Study in Advanced Parkinson's Disease Patients With Predictable Motor Fluctuations
Not yet reported Depomed 34 participants Est. completion 2012-10 7 sites Stand-aloneOther conditions: Parkinson's Disease, Motor FluctuationsView official trial listing → -
Completed NCT NCT01519284
Study of BIA 9-1067 to Investigate Its Effect on Levodopa Pharmacokinetic
Not yet reported Bial - Portela C S.A. 82 participants Est. completion 2011-06 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01528592
PharmacoMRI of Parkinson Disease
Not yet reported Northwestern University 18 participants Est. completion 2012-07 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01533077
Pharmacokinetic Interaction Between BIA 9-1067 and Standard-release Levodopa/Carbidopa
Not yet reported Bial - Portela C S.A. 18 participants Est. completion 2010-02 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01533116
Effect of BIA 9-1067 at Steady-state on the Pharmacokinetics of Levodopa/Carbidopa and Levodopa/Benserazide
Not yet reported Bial - Portela C S.A. 52 participants Est. completion 2010-03 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Terminated NCT NCT01536015
Effect of Rotigotine on Motor Symptoms in Patients With Advanced Parkinson's Disease (PD) With Motor Fluctuations and Symptoms of Gastrointestinal Dysfunction
Not yet reported UCB Pharma 25 participants Est. completion 2013-10 26 sitesOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01538329
Amantadine and L-DOPA-induced Dyskinesia in Early Parkinson's Disease
Not yet reported University Hospital, Toulouse 210 participants Est. completion 2019-02-26 18 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01545856
Cardiovascular Events in Parkinson's Disease Patients
GlaxoSmithKline 1 participants Est. completion 2011-11Other conditions: Cardiovascular Event, Parkinson DiseaseView official trial listing → -
Completed NCT NCT01556165
Rasagiline in Early Parkinson's Disease Patients Not Treated With Levodopa in China
Not yet reported H. Lundbeck A/S 130 participants 15 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01568034
A Study to Investigate the Tolerability and Effect of Three Single-dose Regimens of BIA 9-1067
Not yet reported Bial - Portela C S.A. 10 participants Est. completion 2010-02 3 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01568047
Multicentre Study in Four Parallel Groups of Parkinson's Disease (PD) Patients
Not yet reported Bial - Portela C S.A. 40 participants Est. completion 2010-06 7 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01568073
Efficacy and Safety of BIA 9-1067 in Idiopathic Parkinson's Disease Patients With "Wearing-off" Phenomenon
Not yet reported Bial - Portela C S.A. 600 participants Est. completion 2013-11 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01577992
Evaluation of the Subjective and Objective Painful Threshold in Multiple System Atrophy Pain and Multiple System Atrophy
Not yet reported University Hospital, Toulouse 42 participants Est. completion 2013-11-30 1 site Stand-aloneOther conditions: Pain Threshold, Multiple System AtrophyView official trial listing → -
Completed NCT NCT01602549
A Study to Assess the Effect of Repeat Doses of GSK962040 on the Pharmacokinetics of L-DOPA in Subjects With Parkinson's Disease Exhibiting Delayed Gastric Emptying
Not yet reported GlaxoSmithKline 58 participants Est. completion 2014-05 11 sitesOther conditions: GastroparesisView official trial listing → -
Completed NCT NCT01617135
Safety, Pharmacokinetics and Efficacy Study of CVT-301 Inpatients With Parkinson's Disease and "Off" Episodes
Not yet reported Acorda Therapeutics 25 participants Est. completion 2012-12 7 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01620164
Assessment of Three-dimensional Vision Alteration in Parkinson Disease
Not yet reported University Hospital, Toulouse 36 participants Est. completion 2014-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT01628848
A Dose-finding Study for SPM 962 in Advanced Parkinson's Disease Patients
Not yet reported Otsuka Pharmaceutical Co., Ltd. 174 participants Est. completion 2008-04 7 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01628926
A Placebo- and Ropinirole-Controlled Study for SPM 962 in Advanced Parkinson's Disease Patients
Not yet reported Otsuka Pharmaceutical Co., Ltd. 420 participants Est. completion 2011-05 8 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01628965
A Long-Term Extension Trial From Phase II/III of SPM 962 in Early Parkinson's Disease Patients
Not yet reported, Not yet reported Otsuka Pharmaceutical Co., Ltd. 143 participants Est. completion 2010-10 7 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01631825
A Long-Term Extension Trial From of SPM 962 in Advanced Parkinson's Disease Patients
Not yet reported Otsuka Pharmaceutical Co., Ltd. 321 participants Est. completion 2012-06 8 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01636037
Antipsychotic Augmentation With L-Dopa
Not yet reported Centre for Addiction and Mental Health 13 participants Est. completion 2016-01 1 site Stand-aloneOther conditions: SchizophreniaView official trial listing → -
Completed NCT NCT01646255
Rotigotine Versus Placebo, A Study To Evaluate The Efficacy In Advanced Stage Idiopathic Parkinson's Disease Patients
Not yet reported UCB Pharma 346 participants Est. completion 2014-10 24 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT01663935
Vision Response to Dopamine Replacement
Not yet reported University of Wisconsin, Madison 20 participants Est. completion 2018-04-12 1 siteOther conditions: Albinism, Oculocutaneous AlbinismView official trial listing → -
Completed NCT NCT01683253
Remission of ICD by Switching Dopamine Agonist to Levodopa/Carbidopa
Not yet reported Sandoz 150 participants Est. completion 2014-12 5 sites Stand-aloneOther conditions: Impulse Control DisorderView official trial listing → -
Completed NCT NCT01688089
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-103 in Healthy Volunteers
Not yet reported Orion Corporation, Orion Pharma 67 participants Est. completion 2014-09 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01725802
A Safety, Tolerability, and Plasma Concentration Study of Levodopa/Carbidopa Subcutaneous Solution (ND0612) in Parkinson's Disease (PD) Patients
Not yet reported NeuroDerm Ltd. 8 participants Est. completion 2013-02-26 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01736176
A Study to Assess the Safety and Efficacy of Levodopa-carbidopa Intestinal Gel (LCIG) for the Treatment of Non-motor Symptoms in Patients With Advanced Parkinson's Disease
Not yet reported AbbVie (prior sponsor, Abbott) 39 participants Est. completion 2015-12 Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01736891
Clinical Trial of Rasagiline in Levodopa-Treated Parkinson's Disease Patients With Motor Fluctuations
Not yet reported Chongqing Fortune Pharmaceutical Co., Ltd. 268 participants Est. completion 2013-06 8 sitesOther conditions: Parkinson´s DiseaseView official trial listing → -
Completed NCT NCT01754129
Global REsponsE During iNFusIon of a gEl With LevoDopa/Carbidopa
AbbVie (prior sponsor, Abbott) 148 participants Est. completion 2016-05Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01766258
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Motor Fluctuations
Not yet reported Orion Corporation, Orion Pharma 117 participants Est. completion 2012-09 Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01767129
Safety and Efficacy of AVP-923 in the Treatment of Levodopa-induced Dyskinesia in Parkinson's Disease Patients
Not yet reported Avanir Pharmaceuticals 14 participants Est. completion 2015-02-05 3 sitesOther conditions: Dyskinesia, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01770145
Apokyn for Motor IMProvement of Morning AKinesia Trial (AM IMPAKT)
Not yet reported MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 127 participants Est. completion 2014-04 12 sites Stand-aloneOther conditions: Parkinson's Disease, Motor Symptoms, Akinesia, Hypomobility, Delayed Levodopa OnsetView official trial listing → -
Completed NCT NCT01777555
Efficacy and Safety Study of Inhaled CVT 301 in Parkinson's Disease Patients for Treatment of OFF Episodes
Not yet reported Acorda Therapeutics 89 participants Est. completion 2014-01 22 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT01780467
Role of Dopamine on Loss Aversion Behaviour: Study on Parkinsonian Patients
Not yet reported University Hospital, Clermont-Ferrand 40 participants Est. completion 2015-12 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01840423
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of ODM-104 in Healthy Volunteers
Not yet reported Orion Corporation, Orion Pharma 101 participants Est. completion 2014-12 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT01883505
A Safety, Tolerability and Levodopa Pharmacokinetics Study of Repeated ND0612 in Parkinson's Disease Patients
Not yet reported NeuroDerm Ltd. 30 participants Est. completion 2015-04-26 3 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01920425
Kinesia HomeView - Home Diary Comparison
Not yet reported Great Lakes NeuroTechnologies Inc. 2 participants Est. completion 2015-09 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01937078
Famotidine for Levodopa-induced Dyskinesia in PD
Not yet reported University Health Network, Toronto 7 participants Est. completion 2014-03 1 siteOther conditions: DyskinesiaView official trial listing → -
Status unknown NCT NCT01937169
Targeting Dopamine Therapy in RLS
Not yet reported Tel-Aviv Sourasky Medical Center 30 participants 1 site Stand-aloneOther conditions: Restless Legs SyndromeView official trial listing → -
Completed NCT NCT01951105
Effect of L-dopa In Subacute Back Pain Population
Not yet reported Northwestern University 72 participants Est. completion 2017-09-25 1 siteOther conditions: Sub-acute Back PainView official trial listing → -
Completed NCT NCT01956032
Duodopa Home Titration Using Telemedicine: Evaluation of Use of Resources
AbbVie 15 participants Est. completion 2014-11Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01960842
A Study to Assess the Efficacy, Safety and Tolerability of ABT-SLV187 Monotherapy in Subjects With Advanced Parkinson's Disease (PD) and Persistent Motor Complications, Despite Optimized Treatment With Available Anti-Parkinsonian Medications
Not yet reported AbbVie 31 participants Est. completion 2015-03 Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01973543
Safety Study of AADC Gene Therapy (VY-AADC01) for Parkinson's Disease
Not yet reported Neurocrine Biosciences 15 participants Est. completion 2020-01-24 2 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT01996878
Genetic Polymorphism and Parkinson's Disease in Taiwanese
Changhua Christian Hospital 334 participants Est. completion 2013-10 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02005029
Erythromycin in Parkinson's Disease
Not yet reported Virginia Commonwealth University 18 participants Est. completion 2015-06 1 siteOther conditions: Parkinson's Disease, LevodopaView official trial listing → -
Completed NCT NCT02073773
Combinational Rehabilitative Therapy and Functional Brain Imaging for Patients Recovering From Motor Stroke
Not yet reported Singapore General Hospital 9 participants Est. completion 2015-11 1 site Stand-aloneCardiovascular diseaseView official trial listing → -
Completed NCT NCT02080819
Striatal Effective Connectivity to Predict Treatment Response in Cocaine Misuse
Not yet reported Virginia Commonwealth University 131 participants Est. completion 2017-01-21 1 site Stand-aloneOther conditions: Cocaine DependenceView official trial listing → -
Completed NCT NCT02082249
An Extension Study to Assess the Safety, Tolerability and Efficacy of ABT-SLV187 in Subjects With Advanced Parkinson's Disease and Persistent Motor-Complications Despite Optimized Treatment With Available Anti-Parkinsonian Medications
Not yet reported AbbVie 30 participants Est. completion 2019-10-31 7 sitesOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02096601
A Safety, Tolerability, and Pharmacokinetic Study of ND0612 Delivered as a Continuous Subcutaneous in Parkinson's Disease Patients
Not yet reported NeuroDerm Ltd. 16 participants Est. completion 2015-03-15 2 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02112812
Effects of Helicobacter Pylori Infection Eradication in Patients With Parkinson's Disease
Not yet reported National University of Malaysia 82 participants Est. completion 2013-04 1 siteOther conditions: Response to Levodopa, Motor Outcomes, Quality of Life OutcomesView official trial listing → -
Completed NCT NCT02116465
Pharmacokinetic Study With Levodopa-carbidopa Fixed-dose Products in Healthy Subjects After Oral Administration
Not yet reported Desitin Arzneimittel GmbH 12 participants Est. completion 2014-03 1 siteOther conditions: Fasted StateView official trial listing → -
Withdrawn NCT NCT02116790
Efficacy of Co-administration of an NSAID With a Dopamine Agonist In Healthy Subjects
Not yet reported Northwestern University Est. completion 2015-01Other conditions: Acute PainView official trial listing → -
Completed NCT NCT02125825
Ambulatory Parkinson's Disease Dyskinesia Monitor for Drug Therapy Titration
Great Lakes NeuroTechnologies Inc. 14 participants Est. completion 2014-12 2 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02136914
ADS-5102 for the Treatment of Levodopa Induced Dyskinesia (EASE LID Study)
Not yet reported Adamas Pharmaceuticals, Inc. 126 participants Est. completion 2015-12 46 sitesOther conditions: Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02137278
Stop Vasodepressor Drugs in Reflex Syncope
Not yet reported Gruppo Italiano Multidisciplinare per lo Studio della Sincope 58 participants Est. completion 2015-12 1 siteOther conditions: Hypotensive SyncopeView official trial listing → -
Terminated NCT NCT02153632
Efficacy and Safety of Amantadine Hydrogen Chloride (HCl) ER Tablets in Parkinson's Disease Subjects With LID
Not yet reported Adamas Pharmaceuticals, Inc. 135 participants Est. completion 2016-05-20 56 sitesOther conditions: Parkinson's Disease, Levodopa Induced Dyskinesia (LID)View official trial listing → -
Terminated NCT NCT02153645
Efficacy and Safety of Amantadine Hydrochloride (HCl) ER Tablets to Treat Parkinson's Disease Patients With LID.
Not yet reported Adamas Pharmaceuticals, Inc. 87 participants Est. completion 2016-05-20 56 sitesOther conditions: Parkinson's Disease, Levodopa Induced Dyskinesias (LID)View official trial listing → -
Completed NCT NCT02169414
Effect of Three Multiple-dose Regimens of BIA 9 1067 at Steady-state on the Levodopa Pharmacokinetics
Not yet reported Bial - Portela C S.A. 74 participants Est. completion 2010-07 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02169453
Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Carbidopa
Not yet reported Bial - Portela C S.A. 12 participants Est. completion 2009-01 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02169466
Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Controlled-release 100/25 mg Levodopa/Benserazide
Not yet reported Bial - Portela C S.A. 22 participants Est. completion 2009-05 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02169479
Pharmacokinetic-pharmacodynamic Interaction Between Each of Three Diferente Single Doses of BIA 9-1067 and a Single-dose of Immediate-release 100/25 mg Levodopa/Carbidopa
Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2008-12 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02169895
Pharmacokinetic-pharmacodynamic Interaction Between Three Different Single Doses of BIA 9-1067 and a Single-dose of Immediate-release Levodopa/Benserazide
Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2008-11 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02170376
The Effect of BIA 9-1067 at Steady-state on the Levodopa Pharmacokinetics
Not yet reported Bial - Portela C S.A. 80 participants Est. completion 2012-01 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02172573
Safety and Efficacy of Pramipexole and Bromocriptine Combined With L-dopa in Parkinson's Disease
Not yet reported Boehringer Ingelheim 315 participantsOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02177357
Pramipexole in Untreated and Levodopa-treated Parkinson's Disease Patients
Not yet reported Boehringer Ingelheim 150 participantsOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02200887
Sleep Homeostasis in Parkinson's Disease
Salvatore Galati 48 participants Est. completion 2015-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02202551
Open-Label Safety Study of ADS-5102 in PD Patients With LID
Not yet reported Adamas Pharmaceuticals, Inc. 223 participants Est. completion 2018-02 87 sitesOther conditions: Dyskinesia, Levodopa Induced Dyskinesia (LID), Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02224664
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of PF-06649751 in Parkinson's Disease
Not yet reported Pfizer 50 participants Est. completion 2016-03 17 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02227355
Evaluating the Effectiveness of Neupro® (Rotigotine) and L-dopa Combination Therapy in Patients With Parkinson's Disease
UCB Biopharma S.P.R.L. 195 participants Est. completion 2016-06 42 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02239978
Effect of Levodopa on Postural Motor Learning in Parkinson Disease
VA Office of Research and Development 42 participants Est. completion 2016-09 3 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02240030
Efficacy and Safety Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Not yet reported Acorda Therapeutics 351 participants Est. completion 2016-12 74 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02242487
Twelve Month Safety and Efficacy Study of CVT-301 In Parkinson's Disease Patients With OFF Episodes
Not yet reported Acorda Therapeutics 325 participants Est. completion 2018-05 74 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02271503
A Study to Assess the PK and Pharmacodynamics of IPX203 in Patients With Advanced Parkinson's Disease
Not yet reported Impax Laboratories, LLC 26 participants Est. completion 2016-08 11 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02274766
Efficacy and Safety Study of ADS-5102 in PD Patients With Levodopa-Induced Dyskinesia
Not yet reported Adamas Pharmaceuticals, Inc. 77 participants Est. completion 2016-03-10 51 sitesOther conditions: Dyskinesia, Levodopa-Induced Dyskinesia (LID), Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02289729
Patient- and Caregiver-reported Symptoms and Outcomes With Levodopa/Carbidopa Intestinal Gel for the Treatment of Advanced Parkinson's Disease
AbbVie 62 participants Est. completion 2016-11Other conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02312232
Pharmacokinetic Study in Healthy Males
Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2015-02 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02337725
A Phase 3 Study of TVP-1012 (1 mg) in Early Parkinson's Disease Patients
Not yet reported Takeda 244 participants Est. completion 2016-09-15 55 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02337738
A Phase 2/3 Study of TVP-1012 at 0.5 mg or 1 mg in Levodopa Treated Parkinson's Disease Participants
Not yet reported, Not yet reported Takeda 404 participants Est. completion 2016-09-17 57 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02337764
A Long-term, Phase 3 Study of TVP-1012 (1 mg) in Levodopa Treated Parkinson's Disease Participants
Not yet reported Takeda 222 participants Est. completion 2016-09-29 24 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Active, not recruiting NCT NCT02339064
Infusion of Apomorphine: Long-term Safety Study
Not yet reported MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 99 participants Est. completion 2025-12 18 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Withdrawn NCT NCT02346630
Combining Robotic-Assisted Therapy and Pharmacotherapy in Post-Stroke Rehabilitation
Not yet reported Ross D. Zafonte, MD Est. completion 2017-03 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02347059
L-dopa Versus Dopamine Agonists After Subthalamic Nucleus Deep Brain Stimulation in Parkinson's Disease
Not yet reported University of Toronto 40 participants Est. completion 2016-08 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02347254
ExAblate Transcranial MRgFUS for Unilateral Pallidotomy for the Treatment of Parkinson's Disease
Not yet reported InSightec 2 participants Est. completion 2017-12 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02352363
Randomized Safety Study of CVT-301 Compared to an Observational Control Group
Not yet reported Acorda Therapeutics 408 participants Est. completion 2017-05 76 sites Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02381444
Health Related Quality of Life in LCIG Patients and LCIG Eligible Patients Continuing Oral Therapy
AbbVie 136 participants Est. completion 2020-01-07 27 sitesOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02384512
Azilect® In Wearing-Off (AIWO)
Teva Pharma GmbH 261 participants Est. completion 2015-01 140 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02386475
Effect of Serotonin and Levodopa in Ischemic Stroke
Not yet reported Hospital de Granollers 39 participants Est. completion 2019-10-31 1 siteCardiovascular diseaseView official trial listing → -
Status unknown NCT NCT02439125
A Study of Efficacy and Safety of Eltoprazine HCl for Treating Levodopa-induced Dyskinesia in Parkinson's Disease Patients
Not yet reported Amarantus BioScience Holdings, Inc. 60 participants Est. completion 2017-12 1 siteOther conditions: Parkinson's Disease, DyskinesiaView official trial listing → -
Completed NCT NCT02439203
Efficacy and Safety of JM-010 in PD With Levodopa-Induced Dyskinesia
Not yet reported Bukwang Pharmaceutical 30 participants Est. completion 2016-01 1 siteOther conditions: Parkinson's Disease, Levodopa Induced Dyskinesia (LID)View official trial listing → -
Completed NCT NCT02448914
A Study to Compare Plasma Levels of Levodopa, Carbidopa and Entacapone After TRIGEL or Duodopa Infusion in PD Patients
Not yet reported LobSor Pharmaceuticals AB 11 participants Est. completion 2015-07 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02452606
Clock and Narcolepsy Genetic Variants and the Effects of Stalevo® (Levodopa/Carbidopa/Entacapone) on Sleep Disorders in Parkinson's Disease
Not yet reported Asan Medical Center 100 participants Est. completion 2017-05 1 siteOther conditions: Parkinson Disease, Sleep DisordersView official trial listing → -
Terminated NCT NCT02453386
Safety and Efficacy Study of Tozadenant to Treat End of Dose Wearing Off in Parkinson's Patients
Not yet reported Biotie Therapies Inc. 449 participants Est. completion 2018-01-12 71 sitesOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02469090
Efficacy, Safety and Tolerability Study of APL-130277 for the Acute Treatment of OFF Episodes in Patients With Parkinson's Disease
Not yet reported Sumitomo Pharma America, Inc. 141 participants Est. completion 2017-12-11 33 sitesOther conditions: Parkinson Disease, Off EpisodesView official trial listing → -
Completed NCT NCT02480803
INfusion VErsus STimulation in Parkinson's Disease
Not yet reported Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 51 participants Est. completion 2024-01-26 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02485600
Observational Study Evaluating Long-term Health Outcomes of Canadian DUODOPA-treated Patients
AbbVie 88 participants Est. completion 2020-02-26 13 sitesOther conditions: Parkinson Disease (PD)View official trial listing → -
Completed NCT NCT02486432
A Single Period Investigation to Assess the Tolerability of Healthy Subjects to Oral Sinemet® (Levodopa/Carbidopa)
Not yet reported NeuroDerm Ltd. 6 participants Est. completion 2015-04 Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02513485
Inflammation-related Alterations in Neurocircuitry: Reversal With Levodopa
Not yet reported Emory University 57 participants Est. completion 2020-08-01 1 siteOther conditions: DepressionView official trial listing → -
Completed NCT NCT02542696
Open-Label Phase 3 Study to Examine the Long-Term Safety, Tolerability and Efficacy of APL-130277 for the Acute Treatment of "OFF" Episodes in Patients With Parkinson's Disease
Not yet reported Sumitomo Pharma America, Inc. 496 participants Est. completion 2022-11-08 70 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Terminated NCT NCT02549573
Outpatient Physical Therapy Intervention in Subjects With Parkinson's Disease Currently Using APOKYN®
Not yet reported MDD US Operations, LLC a subsidiary of Supernus Pharmaceuticals 13 participants Est. completion 2016-12 12 sitesOther conditions: Parkinson's Disease, Motor SymptomsView official trial listing → -
Completed NCT NCT02554734
Pharmacokinetic Study in Healthy Volunteers
Not yet reported Orion Corporation, Orion Pharma 15 participants Est. completion 2015-11 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02560389
Dopamine Enhancement of Fear Extinction Learning in PTSD (1R21MH108753)
Not yet reported University of Wisconsin, Madison 103 participants Est. completion 2018-05-01 1 siteOther conditions: Stress Disorder, Post TraumaticView official trial listing → -
Completed NCT NCT02577523
A Clinical Study of Efficacy, Safety, Tolerability and PK of ND0612H in Subjects With Advanced Parkinson's Disease
Not yet reported NeuroDerm Ltd. 38 participants Est. completion 2017-01-31 11 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02578849
Common Noradrenergic Mechanisms in Parkinson´s Disease and L-DOPA Induced Dyskinesia
Aarhus University Hospital 45 participants Est. completion 2016-01 1 siteOther conditions: Parkinson´s DiseaseView official trial listing → -
Terminated NCT NCT02589340
Buspirone, in Combination With Amantadine, for the Treatment of Levodopa-induced Dyskinesia
Not yet reported Oregon Health and Science University 6 participants Est. completion 2021-02-23 1 siteOther conditions: Parkinson's Disease, Dyskinesias, Movement DisordersView official trial listing → -
Completed NCT NCT02601586
Effects of PR Oxycodone and of Levodopa, vs Placebo, on Central Neuropathic Pain in Parkinson's Disease
Not yet reported, Not yet reported University Hospital, Toulouse 67 participants Est. completion 2020-11 18 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02604914
A Sequential Two-Part, Open-Label Study in Healthy Male and Female Subjects
Not yet reported NeuroDerm Ltd. 36 participants Est. completion 2016-06-30 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02605434
A Study to Assess the Safety and Efficacy of the of the Gastric-retentive AP-CD/LD in Advanced Parkinson's Patients
Not yet reported Intec Pharma Ltd. 420 participants Est. completion 2019-12 97 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02611713
Observational Study Evaluating Long-Term Effectiveness of Duodopa/Duopa in Patients With Advanced Parkinson's Disease
AbbVie 213 participants Est. completion 2020-12-24 54 sitesOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02615873
A Study of AP-CD/LD in Fluctuating Parkinson's Disease Patients Who Completed IN 11 004
Not yet reported Intec Pharma Ltd. 460 participants Est. completion 2019-12 85 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02617017
Buspirone Treatment of Iatrogenic Dyskinesias in Advanced Parkinson' Disease
Not yet reported Assistance Publique - Hôpitaux de Paris 99 participants Est. completion 2023-03-23 1 siteOther conditions: ParkinsonView official trial listing → -
Completed NCT NCT02633007
A Study of the Safety and Pharmacokinetics of Levodopa Following Administration of CVT 301 (Levodopa Inhalation Powder) in Adults With Asthma
Not yet reported Acorda Therapeutics 25 participants Est. completion 2016-05 3 sites Stand-aloneOther conditions: AsthmaView official trial listing → -
Completed NCT NCT02633839
A Study of the Safety and Levodopa Pharmacokinetics Following Single Dose Administration of CVT 301 (Levodopa Inhalation Powder) in Smoking and Non-Smoking Adults
Not yet reported Acorda Therapeutics 60 participants Est. completion 2016-06 2 sites Stand-aloneOther conditions: SmokingView official trial listing → -
Completed NCT NCT02641054
Efficacy Phase IIa Study of CVXL-0107 in Advanced Parkinson's Disease
Not yet reported CleveXel Pharma 21 participants Est. completion 2017-07 1 site Stand-aloneOther conditions: Idiopathic Parkinson DiseaseView official trial listing → -
Completed NCT NCT02657681
Prevention of Levodopa-induced Dyskinesias by Transcranial Static Magnetic Field Stimulation (tSMS)
Not yet reported Fundación de investigación HM 50 participants Est. completion 2018-09 1 siteOther conditions: Dyskinesia, Medication-Induced, Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02668497
Kinematic-based BoNT-A Bilateral Upper Limb PD Therapy
Not yet reported Western University, Canada 50 participants Est. completion 2020-12 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02680977
Mucuna Pruriens Therapy in Parkinson's Disease
Not yet reported ASST Gaetano Pini-CTO 18 participants Est. completion 2016-09 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02696512
A Study of IBRF Disorders of Consciousness Advanced Care/MultiModal Care Protocol in Severe Disorders of Consciousness
Not yet reported, Not yet reported International Brain Research Foundation 30 participants Est. completion 2017-04 1 site Stand-aloneOther conditions: Brain InjuryView official trial listing → -
Completed NCT NCT02701803
Parkinson's KinetiGraph, PKG in Patients With Deep Brain Stimulation and Continuous Levodopa Infusion Therapy
Hospital District of Helsinki and Uusimaa 8 participants Est. completion 2018-06 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02706977
The Effect of Dopamine on Diabetic Retinopathy
Not yet reported Emory University 60 participants Est. completion 2019-08-15 1 site Stand-aloneOther conditions: DiabetesView official trial listing → -
Active, not recruiting NCT NCT02726386
A Long Term Safety Study of ND0612 Administered as a Continuous SC Infusion in Advanced Parkinson's Disease
Not yet reported NeuroDerm Ltd. 214 participants Est. completion 2027-02 57 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02741947
Levodopa Benserazide Generic Formulation Versus the Originator
Not yet reported IRCCS San Raffaele Roma 44 participants Est. completion 2015-12 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02744391
A Study of L-DOPA for Depression and Slowing in Older Adults
Not yet reported New York State Psychiatric Institute 47 participants Est. completion 2018-11-30 1 site Stand-aloneOther conditions: Major Depressive Disorder, Dysthymia, Depression Not Otherwise Specified, Decreased Processing Speed, Decreased Gait SpeedView official trial listing → -
Completed NCT NCT02763137
Intermittent Oral Administration vs. Semi-continuous Intra-oral Administration of Levodopa/Carbidopa in Fluctuating Parkinsonian Patients
Not yet reported IRCCS San Raffaele Roma 18 participants Est. completion 2015-10 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02763839
Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Carbidopa (100/25 mg)
Not yet reported Bial - Portela C S.A. 19 participants Est. completion 2001-07 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02763852
Pharmacokinetic-Pharmacodynamic Interaction Between Four Different Single Doses of BIA 3-202 and a Single Dose of Levodopa/Benserazide (100/25 mg)
Not yet reported Bial - Portela C S.A. 18 participants Est. completion 2001-07 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02764125
Efficacy and Safety Proof of Concept Study in Patients With Parkinson's Disease and End-of-dose Wearing-off (COMPOC)
Not yet reported Orion Corporation, Orion Pharma 84 participants Est. completion 2018-03-27 4 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02769793
Efficacy of Levodopa/Benserazide Dispersible Tablet on Response Fluctuations in PD Patients With Delayed ON
Not yet reported Seoul National University Hospital 40 participants Est. completion 2018-12 2 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02774564
Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Carbidopa
Not yet reported Bial - Portela C S.A. 16 participants Est. completion 2005-11 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02778594
Pharmacokinetic-pharmacodynamic Interaction Between BIA 3-202 and Levodopa/Benserazide
Not yet reported Bial - Portela C S.A. 17 participants Est. completion 2005-11 1 site Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Withdrawn NCT NCT02782481
A Clinical Study Investigating the Efficacy, Tolerability, and Safety of Continuous Subcutaneous ND0612 Infusion Given as Adjunct Treatment to Oral Levodopa in Patients With Parkinson's Disease With Motor Fluctuations
Not yet reported NeuroDerm Ltd. Est. completion 2018-10-15 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT02785978
Pilot Study to Evaluate ActiMyo Measured Activity in Parkinson Disease Patients & Healthy Volunteers
Not yet reported Institut de Myologie, France 30 participants Est. completion 2017-07 3 sites Stand-aloneOther conditions: Parkinson Disease, Healthy VolunteersView official trial listing → -
Completed NCT NCT02799381
A Study Comparing Efficacy of Levodopa-Carbidopa Intestinal Gel/Carbidopa-Levodopa Enteral Suspension and Optimized Medical Treatment on Dyskinesia in Subjects With Advanced Parkinson's Disease (DYSCOVER)
Not yet reported AbbVie 63 participants Est. completion 2019-09-19 28 sites Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT02807675
A Study of the Safety and Tolerability of a Single Dose Administration of CVT-301 (Levodopa Inhalation Powder)
Not yet reported Acorda Therapeutics 36 participants Est. completion 2016-11 11 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT02812147
Effect of L-Dihydoxyphenylserine on Locomotion, Postural Stability, and Fall Risk Reduction in Parkinson Disease
Not yet reported St. Joseph's Hospital and Medical Center, Phoenix 20 participants Est. completion 2019-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02812394
A Study to Compare Two Dose Strengths of CVT-301 (Levodopa Inhalation Powder) With an Oral Dose of Sinemet® (Carbidopa-levodopa) Tablets
Not yet reported Acorda Therapeutics 24 participants Est. completion 2016-09 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT02834507
Effect of Two Multiple-dose Regimens of BIA 3-202 on the Pharmacokinetics and Motor Response of Levodopa, and on the Erythrocyte Comt Activity in Parkinson's Disease Patients
Not yet reported Bial - Portela C S.A. 19 participants Est. completion 2005-11 Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Status unknown NCT NCT02837640
Studying a Potential Protective Effect of L-Dopa on Retinitis Pigmentosa
Not yet reported Beirut Eye Specialist Hospital 50 participants Est. completion 2021-06 1 site Stand-aloneObstructive sleep apneaView official trial listing → -
Completed NCT NCT02847442
Efficacy and Safety of Opicapone in Clinical Practice
Not yet reported Bial - Portela C S.A. 518 participants Est. completion 2018-07-04 1 site Stand-aloneOther conditions: Parkinson's Disease With Wearing-off Motor FluctuationsView official trial listing → -
Terminated NCT NCT02863640
Evaluation of the Protective Role of the L-DOPA Against Age Related Macular Degeneration in Parkinson's Patients
Fondation Ophtalmologique Adolphe de Rothschild 13 participants Est. completion 2017-12-18 1 siteOther conditions: Macular Degeneration, SenileView official trial listing → -
Withdrawn NCT NCT02873351
A Safety and Efficacy Study of Carbidopa-levodopa in Patients With Macular Degeneration
Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. Est. completion 2020-12 1 site Stand-aloneOther conditions: Age-related Macular DegenerationView official trial listing → -
Terminated NCT NCT02896816
EMG Modules as a Novel Biomarker of Basal Ganglia Plasticity in Parkinson's Disease
Not yet reported Spaulding Rehabilitation Hospital 17 participants Est. completion 2021-05-25 1 site Stand-aloneOther conditions: ParkinsonView official trial listing → -
Completed NCT NCT02952014
Assessment of a Pre-Workout Dietary Supplement
Not yet reported Texas A&M University 31 participants Est. completion 2014-05 1 siteOther conditions: Dietary ModificationView official trial listing → -
Active, not recruiting NCT NCT02994719
Gait Analysis in Neurological Disease
Beth Israel Deaconess Medical Center 120 participants Est. completion 2027-07-07 1 siteOther conditions: Parkinson's Disease, Parkinsonian Disorders, Atypical Parkinson Disease, Progressive Supranuclear Palsy, Multiple System Atrophy, Corticobasal Degeneration, Gait, Frontal, Huntington Disease, Ataxia, SpinocerebellarView official trial listing → -
Completed NCT NCT03000569
A Study to Evaluate SAGE-217 in Participants With Parkinson's Disease
Not yet reported Biogen 29 participants Est. completion 2017-09-11 11 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03007888
A Study to Assess the PK and Pharmacodynamics of IPX203 in Subjects With Advanced Parkinson's Disease
Not yet reported Impax Laboratories, LLC 28 participants Est. completion 2017-08-01 11 sites Stand-aloneOther conditions: Advanced Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03022318
Carbidopa-levodopa in Neovascular AMD
Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 20 participants Est. completion 2020-05-04 1 site Stand-aloneOther conditions: Age-related Macular DegenerationView official trial listing → -
Completed NCT NCT03023059
Dose Ranging Study of Carbidopa-levodopa
Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 35 participants Est. completion 2020-05-04 1 site Stand-aloneOther conditions: Age-related Macular DegenerationView official trial listing → -
Terminated NCT NCT03051607
Safety and Tolerability of Tozadenant as Adjunctive Therapy in Levodopa-Treated Patients With Parkinson's Disease.
Not yet reported Biotie Therapies Inc. 66 participants Est. completion 2018-01-16 35 sitesOther conditions: Idiopathic Parkinson DiseaseView official trial listing → -
Completed NCT NCT03055936
Dose-finding Pharmacokinetic Study in Healthy Males
Not yet reported Orion Corporation, Orion Pharma 56 participants Est. completion 2017-06-09 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT03065192
Safety and Efficacy Study of VY-AADC01 for Advanced Parkinson's Disease
Not yet reported Neurocrine Biosciences 16 participants Est. completion 2021-08-10 4 sitesOther conditions: Idiopathic Parkinson's Disease, Parkinson's Disease, Basal Ganglia Disease, Brain Diseases, Central Nervous System Diseases, Movement Disorders, Nervous System Diseases, Neurodegenerative Diseases, Parkinsonian DisordersView official trial listing → -
Completed NCT NCT03091543
Tolerability, Safety and Pharmacokinetics of Four Single-doses of BIA 6-512 (Trans-resveratrol) and Their Effect on the Levodopa Pharmacokinetics
Not yet reported Bial - Portela C S.A. 20 participants Est. completion 2004-07-23 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03091868
Pharmacokinetics of Rising Single-doses of BIA 6-512 and Their Effect on the Levodopa Pharmacokinetics
Not yet reported Bial - Portela C S.A. 80 participants Est. completion 2005-02-28 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03094156
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics
Not yet reported Bial - Portela C S.A. 39 participants Est. completion 2006-07-11 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03097211
Effect of BIA 6-512 at Steady-state on the Levodopa Pharmacokinetics With a Single-dose of Levodopa/Benserazide 200/50 mg or With a Single-dose of Levodopa/Benserazide 200/50 mg Plus a Single-dose of Nebicapone 150 mg
Not yet reported Bial - Portela C S.A. 38 participants Est. completion 2006-10-20 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03103399
Efficacy and Tolerability of Nebicapone in Parkinson's Disease Patients With "Wearingoff" Phenomenon
Not yet reported Bial - Portela C S.A. 254 participants Est. completion 2007-09-21 Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03111485
Effect of Long-acting Levodopa on Obstructive Sleep Apnea in Parkinson's Disease
Not yet reported McGill University Health Centre/Research Institute of the McGill University Health Centre 36 participants Est. completion 2022-10-28 1 site Stand-aloneObstructive sleep apnea Other conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT03119636
Safety and Efficacy Study of Human ESC-derived Neural Precursor Cells in the Treatment of Parkinson's Disease
Not yet reported, Not yet reported Chinese Academy of Sciences 50 participants Est. completion 2020-12 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03129451
The Microbiome in Parkinson's Disease
Corewell Health West 23 participants Est. completion 2021-01-07 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03140956
Pharmacokinetic of Levodopa Study in Healthy Males
Not yet reported Orion Corporation, Orion Pharma 20 participants Est. completion 2017-08-03 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03151460
Dopaminergic Modulation of Declarative Memory
Not yet reported I.R.C.C.S. Fondazione Santa Lucia 40 participants Est. completion 2016-04 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03162874
Study to Evaluate the Efficacy, Safety and Tolerability of PXT002331 (Foliglurax) in Reducing Motor Complications of Levodopa Therapy in Parkinson Disease's Patients
Not yet reported Prexton Therapeutics 157 participants Est. completion 2020-03-02 45 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03197493
Extension, Carbidopa-levodopa in Neovascular Age-related Macular Degeneration (AMD)
Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 35 participants Est. completion 2020-07-09 1 site Stand-aloneOther conditions: Macula; Degeneration, RetinaView official trial listing → -
Completed NCT NCT03205956
Measuring Parkinson's Disease Progression
Not yet reported Kevin J. Black, MD 31 participants Est. completion 2019-10-19 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03235037
Clinical Trial of Levodopa/Carbidopa ( Sinemet) Therapy in Angel Man Syndrome
Not yet reported Bennett Lavenstein 10 participants Est. completion 2019-02-01Other conditions: Angelman SyndromeView official trial listing → -
Status unknown NCT NCT03243552
Proof of Mechanism Study for the Treatment of Social Anhedonia in ASD
Not yet reported University of California, Los Angeles 56 participants Est. completion 2023-12 1 siteOther conditions: ASDView official trial listing → -
Terminated NCT NCT03250117
Relative Bioavailability Study of Ropinirole Implants in Parkinson's Patients on L-Dopa Switched From Oral Ropinirole
Not yet reported, Not yet reported Titan Pharmaceuticals 6 participants Est. completion 2018-05-22 3 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Withdrawn NCT NCT03331848
Study to Evaluate the Efficacy, Safety, and Tolerability of PXT002331 (Foliglurax) in Reducing Levodopa-Induced Dyskinesia and Wearing OFF in Subjects With Parkinson's Disease Experiencing Motor Complications of Levodopa Therapy (ATTUNED)
Not yet reported Prexton Therapeutics Est. completion 2019-02-01Other conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03333369
Exceptional Experiences (EE), Salience & Dopaminergic Neurotransmission
Not yet reported University of Zurich 65 participants Est. completion 2015-08-13 1 siteOther conditions: Healthy, Schizotypal PersonalityView official trial listing → -
Completed NCT NCT03336307
Predictors of Gait Improvement in Patients With Parkinson's Disease After Rehabilitation
University of Roma La Sapienza 36 participants Est. completion 2017-07 1 siteOther conditions: Parkinson Disease, Movement DisordersView official trial listing → -
Completed NCT NCT03354455
Investigating the Causal Role of preSMA in Levodopa-induced Dyskinesia in Parkinson's Disease
Not yet reported Danish Research Centre for Magnetic Resonance 20 participants Est. completion 2018-09-16 1 siteOther conditions: Dyskinesia, Drug-Induced, Parkinson DiseaseView official trial listing → -
Completed NCT NCT03368170
Efficacy and Tolerability of IRL790 in Parkinson's Disease Dyskinesia
Not yet reported Integrative Research Laboratories AB 75 participants Est. completion 2019-06-12 20 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03374917
A Study in Subjects With Parkinson's Disease to Evaluate the Safety and Tolerability of Titration and Continuous Subcutaneous Infusion of ABBV-951 in an Outpatient Environment
Not yet reported AbbVie 20 participants Est. completion 2019-03-04 12 sitesOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT03391882
A Study of an Investigational Drug to See How it Affects the People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes) Compared to an Approved Drug Used to Treat People With Parkinson's Disease Complicated by Motor Fluctuations ("OFF" Episodes)
Not yet reported Sumitomo Pharma America, Inc. 113 participants Est. completion 2021-08-11 31 sitesOther conditions: Motor OFF Episodes Associated With Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03415984
Prevalence of Age Related Macular Degeneration (ARMD) in Parkinson's Patients and Assesment of the Role of L-DOPA
Fondation Ophtalmologique Adolphe de Rothschild 133 participants Est. completion 2019-01-15 1 siteOther conditions: Parkinson Disease, Age Related Macular DegenerationView official trial listing → -
Completed NCT NCT03419806
Study Comparing Intravenous and Subcutaneous Infudopa With Intestinal Duodopa in Patients With Parkinson's Disease
Not yet reported Vastra Gotaland Region 25 participants Est. completion 2020-04-20 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Terminated NCT NCT03451500
Carbidopa-Levodopa in Dry AMD With Geographic Atrophy
Not yet reported Snyder, Robert W., M.D., Ph.D., P.C. 7 participants Est. completion 2019-10-31 1 site Stand-aloneOther conditions: Age Related Macular DegenerationView official trial listing → -
Withdrawn NCT NCT03462043
A Study in Patients With Advanced Parkinson's Disease to Assess the Relative Bioavailability of Levodopa Administered as ND0612 Subcutaneous Infusion Versus Levodopa Administered as Carbidopa-Levodopa Enteral Suspension
Not yet reported NeuroDerm Ltd. Est. completion 2018-12-30 1 siteOther conditions: ParkinsonView official trial listing → -
Completed NCT NCT03496870
A Study of the Pharmacokinetics, Pharmacodynamics, and Safety of Opicapone in Subjects With Parkinson's Disease Taking Levodopa.
Not yet reported Neurocrine Biosciences 16 participants Est. completion 2018-07-02 3 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03517059
Study of Dysarthria, and the Appearance of Non-dopaminergic Signs in Idiopathic PARKinson's Disease
University Hospital, Lille 29 participants Est. completion 2018-11-12 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03521635
The SUSTAIN Study Compares the Effects of Sustained and Immediate-release Pramipexole on the noctUrnal Symptoms of paTients With Advanced ParkInsoN's Disease Who Also Take L-Dopa
Not yet reported Boehringer Ingelheim 98 participants Est. completion 2020-01-07 12 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03531060
A Clinical Study of IRL790 in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
Not yet reported, Not yet reported Integrative Research Laboratories AB 15 participants Est. completion 2017-04-12Other conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03541356
Therapeutic Potential for Intranasal Levodopa in Parkinson's Disease -Off Reversal
Not yet reported Impel Pharmaceuticals 32 participants Est. completion 2019-06-11 5 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03562494
VY-AADC02 for Parkinson's Disease With Motor Fluctuations (RESTORE-1)
Not yet reported Neurocrine Biosciences 14 participants Est. completion 2024-10-30 11 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT03576638
Study to Assess Pharmacokinetics of Accordion Pill Carbidopa-Levodopa Compared to Immediate Release Carbidopa-Levodopa in Parkinson's Disease Patients
Not yet reported Intec Pharma Ltd. 12 participants Est. completion 2019-01 Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03581305
PET Imaging of the Dopaminergic and Serotonergic Systems in Treated HIV Positive Subjects
Not yet reported National Institutes of Health Clinical Center (CC) 46 participants Est. completion 2022-04-06 1 siteOther conditions: Depression, HIV Infections, HIV-Associated Cognitive Motor ComplexView official trial listing → -
Completed NCT NCT03591757
Short-term Effects of TOLCAPONE on Transthyretin Stability in Subjects With Leptomeningeal TTR Amyloidosis (ATTR)
Not yet reported Boston University 10 participants Est. completion 2019-04-26 1 site Stand-aloneOther conditions: Transthyretin Amyloidosis, Amyloidosis, Leptomeningeal, Transthyretin-RelatedView official trial listing → -
Completed NCT NCT03599726
Improving Walking Automaticity in Parkinson's Disease: Levodopa or Donepezil
Not yet reported Oregon Health and Science University 20 participants Est. completion 2019-07-30 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT03602924
Long-term Safety and Effectiveness of Levodopa-carbidopa Intestinal Gel Infusion
Hospital Universitari Vall d'Hebron Research Institute 40 participants Est. completion 2018-12-31 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT03648671
Pain in Parkinson's Disease With Motor Fluctuations.
Universita di Verona 48 participants Est. completion 2019-11-30 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03648905
Clinical Laboratory Evaluation of Chronic Autonomic Failure
National Institute of Neurological Disorders and Stroke (NINDS) 89 participants Est. completion 2026-07-15 1 siteOther conditions: Parkinson's Disease, Multiple System Atrophy, Autonomic FailureView official trial listing → -
Completed NCT NCT03665454
PF 06412562 in Subjects With Advanced Stage Parkinson's Disease
Not yet reported Milton S. Hershey Medical Center 8 participants Est. completion 2019-04-21 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03665493
Dopamine Effect on Inhibitory Control
Not yet reported Giovanni Mirabella 90 participants Est. completion 2023-11-10 1 site Stand-aloneOther conditions: Idiopathic Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03670953
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson's Disease Participants With Motor Fluctuations
Not yet reported Impax Laboratories, LLC 630 participants Est. completion 2021-06-15 108 sitesOther conditions: Parkinson's Disease (Disorder)View official trial listing → -
Completed NCT NCT03703570
A Study of KW-6356 in Patients With Parkinson's Disease on Treatment With Levodopa-containing Preparations
Not yet reported Kyowa Kirin Co., Ltd. 502 participants Est. completion 2020-04-15 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03733496
Observational, Long-term Extension Study for Participants of Prior VY-AADC01 Studies
Neurocrine Biosciences 14 participants Est. completion 2023-07-18 3 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Active, not recruiting NCT NCT03735901
Enhancement of Stroke Rehabilitation With Levodopa
Not yet reported University Hospital, Basel, Switzerland 610 participants Est. completion 2029-06-30 24 sitesCardiovascular diseaseView official trial listing → -
Completed NCT NCT03754062
Pharmacological Modulation of Belief Salience
Not yet reported King's College London 30 participants Est. completion 2019-09-01 1 siteOther conditions: Haloperidol, Placebo, L-DOPAView official trial listing → -
Completed NCT NCT03761004
WD-1603 PK Study in Healthy Volunteers
Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2019-09-05 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Terminated NCT NCT03761030
L-DOPA vs. Placebo for Depression and Psychomotor Slowing in Older Adults
Not yet reported New York State Psychiatric Institute 51 participants Est. completion 2021-09-08 1 site Stand-aloneOther conditions: Major Depressive Disorder, Dysthymia, DepressionView official trial listing → -
Completed NCT NCT03778294
18F-DOPA-PET/MRI Scan in Imaging Elderly Patients With Newly Diagnosed Grade IV Malignant Glioma or Glioblastoma During Planning for a Short Course of Proton Beam Radiation Therapy
Not yet reported Mayo Clinic 43 participants Est. completion 2023-11-26 2 sitesOther conditions: Glioblastoma, Malignant GliomaView official trial listing → -
Completed NCT NCT03781167
A Study to Evaluate the Safety and Tolerability of ABBV-951 in Subjects With Parkinson's Disease (PD)
Not yet reported AbbVie 244 participants Est. completion 2022-08-17 65 sitesOther conditions: Parkinson's Disease (PD)View official trial listing → -
Status unknown NCT NCT03793491
Personality, as a Predictive Factor of Therapeutic Response on Quality of Life After Continuous Perfusion of Dopaminergic Drugs, in Parkinson's Disease
University Hospital, Toulouse 60 participants Est. completion 2021-06-18 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03841604
Effect of Safinamide on Parkinson's Disease Related Chronic Pain
Not yet reported Zambon SpA 94 participants Est. completion 2021-05-03 45 sitesOther conditions: Idiopathic Parkinson DiseaseView official trial listing → -
Completed NCT NCT03872557
Modulating Glucose Tolerance With Dietary Tyrosine
Not yet reported Columbia University 10 participants Est. completion 2020-01-24 1 siteOther conditions: Glucose ToleranceView official trial listing → -
Completed NCT NCT03881371
A Study to Evaluate the Efficacy and Safety of Safinamide, as add-on Therapy, in Idiopathic Chinese Parkinson's Disease (PD) Patients With Motor Fluctuations Treated With Stable Doses of Levodopa
Not yet reported Zambon SpA 307 participants Est. completion 2021-08-20 31 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03887884
Pharmacokinetic Study of CVT-301 (Levodopa Inhalation Powder)
Not yet reported Acorda Therapeutics 23 participants Est. completion 2019-06-28 5 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT03891095
Oxytocin and Dopamine's Effect on Vicarious Optimism
Not yet reported Beijing Normal University 156 participants Est. completion 2019-01-16 1 siteOther conditions: Oxytocin Group, L-DOPA Group, Placebo GroupView official trial listing → -
Completed NCT NCT03918616
P2X7 Receptor, Inflammation and Neurodegenerative Diseases
University of Pisa 50 participants Est. completion 2019-03-30 1 siteOther conditions: Neuro-Degenerative DiseaseView official trial listing → -
Terminated NCT NCT03922711
A Study to Assess the Safety and Effectiveness of Pridopidine Compared to Placebo in the Treatment of Levodopa-Induced Dyskinesia in Patients With Parkinson's Disease
Not yet reported Prilenia 23 participants Est. completion 2020-07-22 33 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT03929068
Sinemet for Spasticity and Function in Amyotrophic Lateral Sclerosis and Primary Lateral Sclerosis
Not yet reported Washington University School of Medicine 15 participants Est. completion 2022-07-08 1 siteOther conditions: Amyotrophic Lateral Sclerosis, Motor Neuron DiseaseView official trial listing → -
Completed NCT NCT03944785
Clinical Outcome Assessment of Parkinson's Disease Patients Treated With XADAGO (Safinamide)
Supernus Pharmaceuticals, Inc. 164 participants Est. completion 2020-01-10 30 sitesOther conditions: Idiopathic Parkinson DiseaseView official trial listing → -
Completed NCT NCT03959540
Safety and Effectiveness of Opicapone Plus Standard of Care in Elderly Patients With Parkinson's Disease
Bial - Portela C S.A. 39 participants Est. completion 2021-05-11 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT03982953
Predicting Cognition After DBS for Parkinson's Disease
Charite University, Berlin, Germany 60 participants Est. completion 2022-08-10 1 siteOther conditions: Parkinson's Disease, Deep Brain Stimulation, Postoperativeneurocognitive Deficit, Postoperative DeliriumView official trial listing → -
Withdrawn NCT NCT03987750
Safinamide for Levodopa-induced Dyskinesia (PD-LID)
Not yet reported Zambon SpA Est. completion 2021-05Other conditions: Dyskinesia, Drug-Induced, Parkinson DiseaseView official trial listing → -
Completed NCT NCT03994328
An Observational Study on Safinamide, Rasagiline and Other Standard of Care in PD
Zambon SpA 1235 participants Est. completion 2023-12-31 3 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Suspended NCT NCT04000919
Effects of 5HTP and LDOPA on CNS Excitability After SCI
Not yet reported, Not yet reported Jessica M D'Amico 30 participants Est. completion 2023-12-30 1 siteOther conditions: Spinal Cord InjuriesView official trial listing → -
Active, not recruiting NCT NCT04006210
Efficacy, Safety and Tolerability Study of ND0612 vs. Oral Immediate Release Levodopa/Carbidopa (IR-LD/CD) in Subjects With Parkinson's Disease Experiencing Motor Fluctuations
Not yet reported NeuroDerm Ltd. 381 participants Est. completion 2027-02 103 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT04052776
Acute Effects of Pharmacological Neuromodulation on Leg Motor Activity in Patients With SCI Treated With EES
Not yet reported Centre Hospitalier Universitaire Vaudois 3 participants Est. completion 2023-10-04 1 siteOther conditions: Spinal Cord Injuries, Drug EffectView official trial listing → -
Status unknown NCT NCT04054960
A Trial of tPCS on Parkinson's Disease OFF State
Not yet reported Western University, Canada 15 participants Est. completion 2021-10 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04064294
Preventing Levodopa Induced Dyskinesia in Parkinson's Disease With HMG-CoA Reductase Inhibitors
VA Office of Research and Development 93 participants Est. completion 2024-03-31 3 sitesOther conditions: Parkinson Disease, Dyskinesia, Drug-InducedView official trial listing → -
Withdrawn NCT NCT04082715
Transition From Acute to Chronic Back Pain : Effect of L-dopa,Gender,and Associated Brain Plasticity
Not yet reported Second Affiliated Hospital of Wenzhou Medical University Est. completion 2023-12 1 site Stand-aloneOther conditions: Chronic Back PainView official trial listing → -
Status unknown NCT NCT04147949
AV-101 (L-4-chlorokynurenine) in Parkinson's Disease Subjects With Levodopa-Induced Dyskinesia
Not yet reported VistaGen Therapeutics, Inc. 20 participants Est. completion 2024-04Other conditions: Parkinson Disease, Dyskinesia, Medication-Induced, L-Dopa Causing Adverse Effects in Therapeutic UseView official trial listing → -
Status unknown NCT NCT04173832
Clinical Study on Treatment of L-DOPA-Induced Dyskinesia With Tianqi Pingchan Granule Combined With Amantadine
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 100 participants Est. completion 2021-12-31 1 siteOther conditions: L-DOPA-Induced DyskinesiaView official trial listing → -
Status unknown NCT NCT04173845
Double Randomized and Placebo Controlled Trail of Tianqi Pingchan Granule to Prevent Levodopa-Induced Dyskinesia
Not yet reported Xinhua Hospital, Shanghai Jiao Tong University School of Medicine 150 participants Est. completion 2021-12-31 1 siteOther conditions: Levodopa-Induced DyskinesiaView official trial listing → -
Completed NCT NCT04184791
Computational Modeling of 60 Hz Subthalamic Nucleus Deep Brain Stimulation for Gait Disorder in Parkinson's Disease
Not yet reported Northwell Health 24 participants Est. completion 2022-08-31 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04218526
Deep Brain Stimulation of the Cuneiform Nucleus for Levodopa-resistant Freezing of Gait in Parkinson's Disease
Not yet reported Jonathan Jagid 5 participants Est. completion 2024-09-12 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04236921
Bioequivalence Bewteen DopaSnap® (Cabidopa/Levopdoap 25/100 mg Tablet) and Carbidopa/Levodopa 25/100 mg Tablet (Actavis)
Not yet reported Riverside Pharmacueticals Corporation 57 participants Est. completion 2019-12-01 1 siteOther conditions: OtherView official trial listing → -
Suspended NCT NCT04244058
Changes in Glutamatergic Neurotransmission of Severe TBI Patients
Not yet reported Weill Medical College of Cornell University 30 participants Est. completion 2023-06-30 1 siteOther conditions: Disorder of Consciousness, Traumatic Brain InjuryView official trial listing → -
Completed NCT NCT04308135
Differences Between Patients With Vascular Parkinsonism and Parkinson's Disease
Ain Shams University 104 participants Est. completion 2022-04-01 1 siteOther conditions: Vascular Parkinsonism, Parkinson's DiseaseView official trial listing → -
Completed NCT NCT04332276
Dopaminergic restauratIon by intraVEntriculaire Administration
Not yet reported, Not yet reported University Hospital, Lille 12 participants Est. completion 2024-05-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT04357483
Effect of Thrombin-containing Collagen-based Hemostatic Matrix
Not yet reported Asan Medical Center 60 participants Est. completion 2020-09-30 1 siteOther conditions: Pancreatic TumorView official trial listing → -
Completed NCT NCT04379050
Extension Study To Evaluate Safety And Tolerability Of 24-Hour Daily Exposure Of Continuous Subcutaneous Infusion of ABBV-951 In Adult Participants With Parkinson's Disease
Not yet reported AbbVie 130 participants Est. completion 2026-04-17 51 sitesOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT04380142
Study Comparing Continuous Subcutaneous Infusion Of ABBV-951 With Oral Carbidopa/Levodopa Tablets For Treatment Of Motor Fluctuations In Adult Participants With Advanced Parkinson's Disease
Not yet reported AbbVie 174 participants Est. completion 2021-09-29 76 sites Stand-aloneOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT04435431
A Clinical Study of Mesdopetam in Patients With Parkinson's Disease Experiencing Levodopa Induced Dyskinesia
Not yet reported Integrative Research Laboratories AB 155 participants Est. completion 2022-12-09 44 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT04441697
Sleepiness in Parkinson's Patients With Continuous Dopaminergic Delivery Device or Deep Brain Stimulation
Central Hospital, Nancy, France 30 participants Est. completion 2023-06 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04455074
Validation of the Neuropsychiatric Fluctuations Scale (EFN-VALID))
Not yet reported University Hospital, Grenoble 130 participants Est. completion 2023-03-23 6 sitesOther conditions: Parkinson Disease, Fluctuating Mood SymptomsView official trial listing → -
Completed NCT NCT04469959
Dopaminergic Dysfunction in Late-Life Depression
Not yet reported Vanderbilt University Medical Center 79 participants Est. completion 2026-04-29 2 sites Stand-aloneOther conditions: Late Life Depression, Cognitive Decline, Depressive Disorder, Treatment-Resistant, Levodopa, Gait ImpairmentView official trial listing → -
Terminated NCT NCT04493320
1/2-Dopaminergic Dysfunction in Late-Life Depression (The D3 Study)
Not yet reported New York State Psychiatric Institute 5 participants Est. completion 2021-10-27 1 site Stand-aloneOther conditions: Depression, Cognitive Impairment, Gait ImpairmentView official trial listing → -
Completed NCT NCT04500106
Study to Assess Participant/Caregiver/Investigator Satisfaction of Video-Assisted Telenursing in Adult Participants With Parkinson's Disease Treated With Levodopa-Carbidopa Intestinal Gel
AbbVie 41 participants Est. completion 2021-10-14 13 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT04513340
WD-1603 PK Study Under Fasting and Fed Conditions in Healthy Subjects
Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-02-13 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04542499
Flexible-Dose, Adjunctive Therapy Trial in Adults With Parkinson's Disease With Motor Fluctuations (TEMPO-3)
Not yet reported AbbVie 507 participants Est. completion 2024-02-15 146 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT04553978
A Single Oral Dose, Crossover Comparative PK Study of WD-1603 in Healthy Subjects Under Fasting Conditions
Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-03-18 Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT04590612
Improving Quality of Life in Early Parkinson's Disease
Not yet reported Western University, Canada 30 participants Est. completion 2022-01Other conditions: Parkinson Disease, DepressionView official trial listing → -
Status unknown NCT NCT04591535
PK Study of WD-1603 in Healthy Subjects
Not yet reported Hong Kong WD Pharmaceutical Co., Limited 8 participants Est. completion 2021-03-28 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT04620980
Assessing the Polygenic Burden of Rare Disruptive Mutations in Parkinson's Disease
Neuromed IRCCS 600 participants Est. completion 2024-05-17 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Terminated NCT NCT04650217
Levodopa and Exercise for Older Adults With Depression and Psychomotor Slowing
Not yet reported New York State Psychiatric Institute 1 participants Est. completion 2021-12-31 1 siteOther conditions: Depressive DisorderView official trial listing → -
Completed NCT NCT04723147
DTA (Dopaminergic Therapy for Anhedonia) Study
Not yet reported Emory University 19 participants Est. completion 2023-10-11 1 site Stand-aloneOther conditions: Depression, AnhedoniaView official trial listing → -
Completed NCT NCT04724109
A Study of Equfina® on the Incidences of Adverse Drug Reactions in Participants With Parkinson's Disease (Including Participants With Hepatic Impairment)
Eisai Co., Ltd. 1088 participants Est. completion 2022-10-13 2 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Withdrawn NCT NCT04742348
Research on Translational Outcomes of Alcohol (Project RETRO)
Not yet reported University of Washington Est. completion 2023-08 Stand-aloneAlcohol use disorderView official trial listing → -
Completed NCT NCT04750226
Study To Assess Adverse Events and Change in Disease Activity Of 24-hour Continuous Subcutaneous Infusion Of ABBV-951 In Adult Participants With Advanced Parkinson's Disease
Not yet reported AbbVie 118 participants Est. completion 2026-04-27 52 sitesOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT04778176
Assessing the Pharmacokinetics, Safety, Tolerability and Efficacy of Continuous Oral Levodopa Via the DopaFuse® Delivery System in Parkinson's Disease Patients
Not yet reported SynAgile Corporation 17 participants Est. completion 2022-08-02 5 sites Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT04787965
Opicapone Treatment Initiation Open-Label Study
Neurocrine Biosciences 239 participants Est. completion 2022-08-04 6 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04821687
A Study to Evaluate the add-on Efficacy and Safety of Opicapone 50 mg or an Extra Dose of L-DOPA 100 mg for the Treatment of Wearing-off in Patients With PD
Not yet reported SK Chemicals Co., Ltd. 169 participants Est. completion 2022-08-18 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04821830
Vigor and the LDR in Parkinson Disease
Not yet reported University of Michigan 19 participants Est. completion 2024-04-25 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Suspended NCT NCT04912115
Randomized, Double-Blind, Active Placebo-Controlled Study of Ketamine to Treat Levodopa-Induced Dyskinesia
Not yet reported PharmaTher Inc. 30 participants Est. completion 2024-03-30 7 sitesOther conditions: Dyskinesias, Movement Disorders, Central Nervous System Diseases, Nervous System Diseases, Neurologic ManifestationsView official trial listing → -
Status unknown NCT NCT04952194
Clinical Study of Stalevo in the Treatment of Early Parkinson's Disease
Not yet reported Second Affiliated Hospital, Zhejiang University, School of Medicine 180 participants Est. completion 2023-12-31 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04956939
Levodopa Response and Gut Microbiome in Patients With Parkinson's Disease
Rush University Medical Center 38 participants Est. completion 2021-03-31 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04978597
Early ParkinSon wIth L-DOPA/DDCI and OpicapoNe (EPSILON Study)
Not yet reported Bial - Portela C S.A. 410 participants Est. completion 2024-01-26 1 siteOther conditions: ParkinsonView official trial listing → -
Completed NCT NCT04986982
OpiCapone Effect on Motor Fluctuations and pAiN
Not yet reported Bial - Portela C S.A. 144 participants Est. completion 2024-02-16 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04986995
OpicApone Sleep dISorder
Not yet reported Bial - Portela C S.A. 22 participants Est. completion 2023-03-29 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT04990284
eArly levoDopa With Opicapone in Parkinson's paTients wIth motOr fluctuatioNs.
Not yet reported Bial - Portela C S.A. 106 participants Est. completion 2023-04-04 25 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05001217
Chinese Herbal Medicine Treatment as Adjunct Therapy for Parkinson's Disease
Not yet reported, Not yet reported Hong Kong Baptist University 160 participants Est. completion 2024-01-31 2 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05036473
A Study of the Efficacy and Safety of Carbidopa-Levodopa Extended-Release Tablets in Patients With Parkinson's Disease
Not yet reported Shanghai WD Pharmaceutical Co., Ltd. 40 participants Est. completion 2022-12-28 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT05043103
Long-Term Observational Study on Effectiveness and Safety of Lecigon in Patients With Advanced Parkinson's Disease
Britannia Pharmaceuticals Ltd. 312 participants Est. completion 2026-10-07 57 sitesOther conditions: Advanced Parkinson DiseaseView official trial listing → -
Completed NCT NCT05083260
NE3107 Activity and Safety in Patients With Parkinson's Disease Using Levodopa
Not yet reported, Not yet reported BioVie Inc. 46 participants Est. completion 2023-01-04 16 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Withdrawn NCT NCT05087914
Novel Non-opioid Post-surgical Pain Treatment in Females
Not yet reported Northwestern University Est. completion 2024-01-30 1 site Stand-aloneOther conditions: Acute Pain, Bunionectomy, Toe FusionView official trial listing → -
Completed NCT NCT05094050
Study to Assess How ABBV-951 is Absorbed When Administered at Different Subcutaneous Sites of Adult Participants With Parkinson's Disease
Not yet reported AbbVie 16 participants Est. completion 2023-03-17 10 sitesOther conditions: Parkinson's DiseaseView official trial listing → -
Terminated NCT NCT05116813
Open-label Safety Study of Dipraglurant (ADX48621) in Patients With Parkinson's Disease Receiving Levodopa-based Therapy
Not yet reported, Not yet reported Addex Pharma S.A. 17 participants Est. completion 2022-08-15 7 sitesOther conditions: Parkinson Disease, Dyskinesia, Drug-Induced, DyskinesiasView official trial listing → -
Completed NCT NCT05119075
Psychological Effects of Levodopa in Parkinson's Disease
Not yet reported Insel Gruppe AG, University Hospital Bern 23 participants Est. completion 2024-03-31 4 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05128175
Comparative Bioavailability Study of Carbidopa/Levodopa Extended-Release Tablets Under Fasting and Fed Conditions
Not yet reported Shanghai WD Pharmaceutical Co., Ltd. 15 participants Est. completion 2021-12-09 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Enrolling by invitation NCT NCT05132660
Treating Early Stage Diabetic Retinopathy
Not yet reported VA Office of Research and Development 244 participants Est. completion 2028-12-31 1 site Stand-aloneOther conditions: Diabetic RetinopathyView official trial listing → -
Completed NCT NCT05148884
Study to Assess the Safety, Tolerability and Preliminary Efficacy of NLX-112 Versus Placebo in L-dopa-induced Dyskinesia
Not yet reported Neurolixis SAS 27 participants Est. completion 2023-01-18 5 sitesOther conditions: Medication-Induced DyskinesiaView official trial listing → -
Completed NCT NCT05204641
Effect of Fecal Microbiota Transfer on Progression of Parkinson Disease
Not yet reported Medical University of Warsaw 59 participants Est. completion 2024-10-08 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05250141
Bioavailability of Levodopa 250 mg and Carbidopa 25 mg With Regards to Reference Product
Not yet reported Laboratorios Andromaco S.A. 44 participants Est. completion 2022-02-17 1 site Stand-aloneOther conditions: BioequivalenceView official trial listing → -
Withdrawn NCT NCT05262348
An Open-label Clinical Trial to Compare the Safety and Effectiveness of Adaptive Versus Conventional Deep Brain Stimulation
Not yet reported Newronika Est. completion 2026-12-31Other conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05297201
Efficacy, Safety and Pharmacokinetic Study of CPL500036 in Patients With Levodopa Induced Dyskinesia
Not yet reported Celon Pharma SA 105 participants Est. completion 2025-01-27 16 sitesOther conditions: Parkinson Disease, Dyskinesia, Medication-InducedView official trial listing → -
Completed NCT NCT05312632
A Study to Evaluate the Efficacy and Safety of Safinamide Mesilate as Add-on Therapy to Levodopa in Parkinson's Disease Participants With Motor Fluctuation in South Korea
Not yet reported Eisai Korea Inc. 201 participants Est. completion 2023-05-25 20 sites Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05369533
Dopaminergic Enhancement of Rehabilitation Therapy Early After Stroke
Not yet reported, Not yet reported University of California, Los Angeles 25 participants Est. completion 2024-03-11 1 siteCardiovascular diseaseView official trial listing → -
Completed NCT NCT05435729
A Pharmacodynamics and Safety Study of DSP-9632P in Patients With Levodopa-Induced Dyskinesia in Parkinson's Disease
Not yet reported Sumitomo Pharma Co., Ltd. 7 participants Est. completion 2022-12-02 1 site Stand-aloneOther conditions: Levodopa-induced Dyskinesia, Parkinson's DiseaseView official trial listing → -
Active, not recruiting NCT NCT05463367
Project 1 Aim 2, Adaptations of the Brain in Chronic Pain With Opioid Exposure
Not yet reported Northwestern University 60 participants Est. completion 2025-06-01 1 site Stand-aloneOther conditions: Opioid Use, Opioid Dependence, Opioid-use Disorder, Narcotic Use, Back Pain, Back Injuries, Chronic Pain, Chronic Low-back Pain, Pain, Chronic, Pain;Back Low;Chronic, Pain, BackView official trial listing → -
Completed NCT NCT05471609
Sustained Release Oral Formulation for Treatment of Parkinson's Disease
Not yet reported University of Minnesota 6 participants Est. completion 2025-08-14 1 site Stand-aloneOther conditions: Healthy VolunteersView official trial listing → -
Completed NCT NCT05487300
Effect of Levodopa on Cardiovascular Autonomic Function in Parkinson's Disease
Not yet reported, Not yet reported University of Utah 40 participants Est. completion 2023-05-01 1 siteOther conditions: Parkinson Disease, Orthostatic HypotensionView official trial listing → -
Status unknown NCT NCT05492019
Effect of Doxycycline in Levodopa Treated Parkinson's Disease Patients
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60 participants Est. completion 2023-01-01 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05499572
Usability of Levodopa Cyclops™ vs INBRIJA® in Parkinson's Patients
Martini Hospital Groningen 16 participants Est. completion 2024-07-02 1 siteOther conditions: UsabilityView official trial listing → -
Completed NCT NCT05523791
Whey Protein Supplementation in Patients With Parkinson's Disease
Not yet reported Ospedale Generale Di Zona Moriggia-Pelascini 51 participants Est. completion 2022-06-30 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05560009
An Imaging Agent (Fluorodopa F 18) With Positron Emission Tomography/Magnetic Resonance Imaging for Assessing Treatment Response in Patients With High-Grade Soft Tissue Sarcomas
Mayo Clinic 9 participants Est. completion 2024-07-09 1 siteOther conditions: Recurrent Soft Tissue Sarcoma, Resectable Soft Tissue Sarcoma, Soft Tissue SarcomaView official trial listing → -
Status unknown NCT NCT05579379
DESENSITIZE-PD: Intestinal Levodopa + Entacapone Therapy (Lecigon®) to Support Dopaminergic Desensitization in PD
University Hospital Tuebingen 20 participants Est. completion 2024-09Other conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05585827
Online Cognitive Behavioral Therapy for Depressive Symptoms in Parkinson's Disease
Not yet reported Helse Stavanger HF 11 participants Est. completion 2024-11-27 1 siteOther conditions: Parkinson Disease, Depressive Symptoms, AnxietyView official trial listing → -
Completed NCT NCT05708274
Pharmacological Agents for Chronic Spinal Cord Injury (SCI)
Not yet reported Bronx VA Medical Center 25 participants Est. completion 2025-10-30 1 site Stand-aloneOther conditions: Spinal Cord InjuriesView official trial listing → -
Status unknown NCT NCT05752240
Transcranial Direct Current Stimulation of the Primary Motor Cortex to Treat Levodopa-induced Dyskinesias
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 32 participants Est. completion 2025-03-10 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05766813
Lenrispodun as Adjunctive Therapy in the Treatment of Patients With Motor Fluctuations Due to Parkinson's Disease
Not yet reported Intra-Cellular Therapies, Inc. 79 participants Est. completion 2025-11-04 35 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT05781321
Short Course Radiotherapy for the Treatment of Patients With Glioblastoma, SAGA Study
Not yet reported Mayo Clinic 170 participants Est. completion 2028-11-30 8 sitesOther conditions: GlioblastomaView official trial listing → -
Completed NCT NCT05781711
Clinical Study to Evaluate the Possible Efficacy of Metformin in Patients With Parkinson's Disease
Not yet reported Tanta University 60 participants Est. completion 2024-08-20 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT05795088
Continuous Theta Burst Stimulation as Potential Biomarker of Levodopa-induced Dyskinesias in Parkinson's Disease
Not yet reported Fondazione Policlinico Universitario Agostino Gemelli IRCCS 60 participants Est. completion 2025-02-28 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT05808504
Investigation of the Benefits of Electrical Non-invasive Stimulation on Cognitive Symptoms in Parkinson's Disease
Not yet reported Institut National de la Santé Et de la Recherche Médicale, France 90 participants Est. completion 2027-09-29 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05885360
Istradefylline Effect Protocol on Parkinson's Disease Tremor
Not yet reported Georgetown University 27 participants Est. completion 2025-02-21 1 site Stand-aloneOther conditions: Parkinson Disease, TremorView official trial listing → -
Completed NCT NCT05901350
The Correlation of Reduction of Levodopa and Non-motor Symptoms of Parkinson's Disease After Deep Brain Stimulation
Not yet reported Qilu Hospital of Shandong University 338 participants Est. completion 2023-01-01 1 site Stand-aloneOther conditions: Parkinson Disease, Visual ImpairmentView official trial listing → -
Status unknown NCT NCT05959044
Effect of Folic Acid in Levodopa Treated Parkinson's Disease Patients
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 60 participants Est. completion 2024-07-16 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT05962957
Role of Pentoxifylline and Celecoxib in Parkinsonism
Not yet reported Mostafa Bahaa 80 participants Est. completion 2024-09-20 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT05976737
Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in Healthy Chinese Subjects
Not yet reported The Affiliated Hospital of Qingdao University 68 participants Est. completion 2024-07-12 Stand-aloneOther conditions: HealthyView official trial listing → -
Terminated NCT NCT06003608
Observational Small Intestine and Blood Fingerprint (SmIle) Study in Parkinson's Disease
Nimble Science Ltd. 51 participants Est. completion 2025-01-01 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT06021756
Phase I Open-label Study of Low-dose Ketamine Infusion Treatment in Levodopa-Induced Dyskinesia in Parkinson's Disease
Not yet reported University of Arizona 9 participants Est. completion 2023-08-25 1 siteOther conditions: Levodopa-Induced Dyskinesia, Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT06034158
Molecular Basis of Loss Aversion
Not yet reported Sir Run Run Shaw Hospital 60 participants Est. completion 2024-09-01 1 siteOther conditions: HealthyView official trial listing → -
Completed NCT NCT06037590
A Pilot Comparative Bioavailability Study of Levodopa Administered Via Levodopa Cyclops® Relative to INBRIJA®
Not yet reported PureIMS B.V. 26 participants Est. completion 2023-10-27 1 site Stand-aloneOther conditions: Parkinson, Parkinson Disease, Parkinson's Disease and ParkinsonismView official trial listing → -
Active, not recruiting NCT NCT06107426
Real-World Study of ABBV-951 Subcutaneous Infusion to Assess Change in Disease Activity in Adult Participants With Parkinson's Disease
AbbVie 427 participants Est. completion 2029-05 68 sitesOther conditions: Parkinson's Disease (PD)View official trial listing → -
Completed NCT NCT06113640
Montelukast in Parkinson Disease
Not yet reported, Not yet reported Mostafa Bahaa 60 participants Est. completion 2026-08-20 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT06115538
Comparison of Dopamin Level in Idiopathic Parkinson's Patients
Not yet reported Ankara Ataturk Sanatorium Training and Research Hospital 96 participants Est. completion 2025-04-30 1 siteOther conditions: Parkinson Disease, Treatment AdherenceView official trial listing → -
Status unknown NCT NCT06180720
Bioequivalence Study of Entacapone,Levodopa and Carbidopa Tablets in the Postprandial State in Healthy Chinese Subjects
Not yet reported The Affiliated Hospital of Qingdao University 36 participants Est. completion 2024-11-20 Stand-aloneOther conditions: HealthyView official trial listing → -
Completed NCT NCT06219915
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Placebo-Controlled Arm
Not yet reported, Not yet reported University of Michigan 13 participants Est. completion 2024-05-30 2 sites Stand-aloneOther conditions: Parkinsonian Signs in Older PersonsView official trial listing → -
Status unknown NCT NCT06225869
Effect of Dopamine on Specific Processing of Shame and Embarrassment in Parkinson's Disease
University Hospital, Geneva 30 participants Est. completion 2025-12 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT06236230
Basic and Clinical Studies of Levodopa/Carbidopa/Entacapone in the Treatment of Early Parkinson's Disease
Not yet reported Second Affiliated Hospital of Soochow University 60 participants Est. completion 2024-12-31 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT06240624
Mapping Levodopa Effects on Cortico-basal Ganglia Circuit Function in Parkinson's Disease
Danish Research Centre for Magnetic Resonance 75 participants Est. completion 2025-12-31 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT06275633
Behavioural Profiling of Disease-related Cognitive and Motor Impairment in PD
Not yet reported University Hospital Bispebjerg and Frederiksberg 68 participants Est. completion 2023-07-30 1 site Stand-aloneOther conditions: Parkinson Disease, Medication, UPDRS, Motor Function, Cognitive Impairment, Depression, Impulsive, LevodopaView official trial listing → -
Status unknown NCT NCT06301282
Electroencephalographic Signatures of Neuropsychiatric Fluctuations in Parkinson's Disease
University Hospital, Geneva 30 participants Est. completion 2025-12 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Status unknown NCT NCT06365190
Effects of a Periodic Repetitive Transcranial Magenetic Stimulation in Parkinson Disease
Not yet reported Anhui Medical University 47 participants Est. completion 2024-07-31 1 siteOther conditions: Transcranial Magnetic Stimulation, Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT06365515
Dopamine, Reward Learning and Sex Hormones
Not yet reported University Hospital Tuebingen 90 participants Est. completion 2025-12 1 site Stand-aloneOther conditions: Hormonal Changes, Menstrual CycleView official trial listing → -
Completed NCT NCT06432309
Opicapone as Adjunctive Therapy to Levodopa-Carbidopa Intestinal Gel in Parkinson's Disease
Not yet reported University Hospital of Ferrara 22 participants Est. completion 2024-04-25 1 siteOther conditions: Parkinson Disease, Effect of DrugView official trial listing → -
Completed NCT NCT06587217
Neurobiological Drivers of Mobility Resilience: The Dopaminergic System - Supplemental Open-Label Arm
Not yet reported, Not yet reported University of Michigan 5 participants Est. completion 2025-04-03 2 sites Stand-aloneOther conditions: Parkinsonian Signs in Older PersonsView official trial listing → -
Status unknown NCT NCT06612593
Cilostazol in Parkinson's Disease
Not yet reported Ain Shams University 50 participants Est. completion 2025-10-01 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT06614153
Pharmacokinetics,Pharmacodynamics,Efficacy and Safety of HRG2010 in Parkinson's Disease Patients With Motor Fluctuations
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 61 participants Est. completion 2024-03-04 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Status unknown NCT NCT06626152
Measuring Psychomotor Response to L-DOPA Challenge As a Biomarker for Outcomes in Late-Life Depression: a Pilot Feasibility Trial
Not yet reported University of British Columbia 50 participants Est. completion 2026-05-30 1 site Stand-aloneOther conditions: Major Depressive DisorderView official trial listing → -
Completed NCT NCT06722729
A Late Phase II Clinical Trial of KDT-3594 in Patients With Parkinson's Disease
Not yet reported Kissei Pharmaceutical Co., Ltd. 178 participants Est. completion 2026-01-14 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT06729658
Dopamine and Brain Computer Interface
Not yet reported Max Planck Institute for Human Cognitive and Brain Sciences 22 participants Est. completion 2024-08-06 1 site Stand-aloneOther conditions: Healthy ParticipantsView official trial listing → -
Not yet recruiting NCT NCT06762028
Exploring the Relationship Between L-dopa Responsiveness and Small Intestinal Microbiome in Parkinson's Disease
University of Calgary 100 participants Est. completion 2027-07-01Other conditions: Parkinson DiseaseView official trial listing → -
Not yet recruiting NCT NCT06936254
One-Year Effect on Levodopa Equivalent Daily Dose of Thalamic VIM Nucleus Stimulation Compared to Subthalamic Nucleus Stimulation in Patients With Parkinson's Disease
Central Hospital, Nancy, France 94 participants Est. completion 2026-09-30 1 siteOther conditions: Parkinson Disease (PD), Deep Brain StimulationView official trial listing → -
Completed NCT NCT06954662
A Targeted Amino Acid Supplement for People With Parkinson's Disease
Not yet reported UConn Health 3 participants Est. completion 2025-07-17 1 site Stand-aloneOther conditions: Parkinson Disease, IdiopathicView official trial listing → -
Completed NCT NCT06976346
Relative Bioavailability Study of HRG2010 in Healthy Subjects
Not yet reported Jiangsu HengRui Medicine Co., Ltd. 16 participants Est. completion 2021-10-07 1 siteOther conditions: Parkinson's DiseaseView official trial listing → -
Completed NCT NCT07001150
Role of Silymarin in Neuroprotection and Symptom Management in Parkinson's Disease
Not yet reported Tanta University 50 participants Est. completion 2026-05-30 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT07055958
Effect of Metformin as Add-on Therapy in Levodopa Treated Parkinson's Disease Patients
Not yet reported Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh 74 participants Est. completion 2025-07-20 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Not yet recruiting NCT NCT07267065
AAV2-hAADC for Parkinson's Disease (PDCS-01)
Not yet reported Russell Lonser 9 participants Est. completion 2029-03-01 1 site Stand-aloneOther conditions: Parkinson's Disease (PD), Early Onset Parkinson DiseaseView official trial listing → -
Terminated NCT NCT07313176
Long Term Effectiveness of Levodopa-Entacapone-Carbidopa Intestinal Gel in Participants With Advanced Parkinson's Disease
Britannia Pharmaceuticals Ltd. 1 participants Est. completion 2026-08-31 4 sitesOther conditions: Advanced Parkinson DiseaseView official trial listing → -
Enrolling by invitation NCT NCT07375693
Effect of Melatonin on Oxidative Stress Parameters in Levodopa-Treated Parkinson's Disease Patients
Not yet reported Bangladesh Medical University 70 participants Est. completion 2026-09-15 1 siteOther conditions: Parkinson DiseaseView official trial listing → -
Active, not recruiting NCT NCT07403799
REal-life ON PARKinson's - ITaly (REONPARK-IT)
Bial - Portela C S.A. 200 participants Est. completion 2029-06-30 20 sitesOther conditions: Parkinson DiseaseView official trial listing → -
Completed NCT NCT07405268
Evaluation of the Effects of Levodopa-Benserazide Drug Combination on Periodontal Status in Patients With Parkinson's Disease
Saglik Bilimleri Universitesi 136 participants Est. completion 2026-11-13 1 siteOther conditions: Parkinson Disease (PD), Periodontitis, Periodontal DiseasesView official trial listing → -
Completed NCT NCT07442591
A Study to Assess Effect of Dosing Intervals on Multiple-Dose Pharmacokinetics of WD-1603 Taken Before Meals in Healthy Participants
Not yet reported Shanghai WD Pharmaceutical Co., Ltd. 12 participants Est. completion 2026-04-23 1 site Stand-aloneOther conditions: HealhtyView official trial listing → -
Completed NCT NCT07444892
Levodopa for Diabetic Retinopathy
Not yet reported Emory University 230 participants Est. completion 2025-11-17 1 site Stand-aloneOther conditions: Diabetic RetinopathyView official trial listing → -
Enrolling by invitation NCT NCT07567599
Deep Brain Stimulation in Parkinson's Disease: Motor and Functional Outcomes
Not yet reported Federal University of Minas Gerais 40 participants Est. completion 2027-02 1 site Stand-aloneOther conditions: Parkinson DiseaseView official trial listing → -
Not yet recruiting NCT NCT07647913
Rhythm Psychophysics With Parkinson's Patients
Not yet reported McMaster University 34 participants Est. completion 2027-10-31 1 site Stand-aloneOther conditions: Parkinson Disease(PD)View official trial listing → -
Not yet recruiting NCT NCT07748715
Brain Dopamine Biomarker
University of South Florida 50 participants Est. completion 2027-09-30Other conditions: Parkinson Disease, Healthy Adult ParticipantsView official trial listing → -
Not yet recruiting NCT NCT07793461
Gastrointestinal Dopamine Decarboxylase and Levodopa Pharmacokinetics
Not yet reported Beth Israel Deaconess Medical Center 40 participants Est. completion 2030-12 1 site Stand-aloneOther conditions: Parkinson's DiseaseView official trial listing → -
Not yet recruiting NCT NCT07806019
Metformin in Parkinson's Disease: Safety and Efficacy
Not yet reported Jinnah Medical & Dental College 70 participants Est. completion 2027-02-01Other conditions: Parkinsons Disease (PD)View official trial listing → -
Completed NCT NCT07917546
Early COMT Inhibition in PD
Not yet reported Neuromed IRCCS 46 participants Est. completion 2025-12-31 1 site Stand-aloneOther conditions: PARKINSON DISEASE (Disorder)View official trial listing → -
Not yet recruiting NCT NCT07925086
Magnetic-Resonance Guided Focused Ultrasound Pallidothalamic Tractotomy for Parkinson's Disease
Not yet reported Research Center of Neurology, Russia 168 participants Est. completion 2032-01-25 1 site Stand-aloneOther conditions: Parkinson Disease (PD)View official trial listing →
Efficacy history
Not yet reported.
Safety
Not yet reported.
Sources
Also known as: Sinemet CR, Levodopa
Related On The Pen coverage
No related coverage yet.
This drug may be investigational and not yet approved for any use. Whether someone can join a clinical trial is determined only by that trial's own study team — On The Pen does not determine eligibility. Information here can change; always confirm current details on the official ClinicalTrials.gov listing or with the sponsor.
